topical review - core · safety and efficacy of a high cumulative dose of salbutamol inhaled via...

Number 1 January 1998

Topical Review

Diaphragm shortening and intrathoracic pressure during hypercapnia in rats

J. D. Pierce, R. L. Clancy, J. W. Trank & J. Burris

Hypo-osmolar aerosol induces hyperventilation in chronic non-asthmatic rhinitics

gagnoli, C. Micheletto & A. Ciaccia

Compartmentalization of pro-inflammatory cytokines in tuberculous pleurisy

G. Hoheisel, G. Izbicki, M. Roth, C. H. S. Chan, J. 6. K. Leung, F. Reichenberger, J. Schauer & A. P. Perruchoud

Serum concentrations of lignocaine and its metabolite monoethylglycinexylidide during fibre-optic bronchoscopy in local anaesthesia

N. Milman, M. Laub, E. P. Munch & H. R. Angelo 40

Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics

H. Bisgaard, K. Nikander & E. Munch 44

Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: a risk factor for

hospitalization and mortality in women

K. Strom 50

Clinical factors that affect blood gases in non-smoking women with chronic liver disease

K. Fujimori & M. Arakawa 57 *;.a,Tma T~~D-~~~,,1%‘~~1~~!~~’ x ‘L ra* -x”1p”,7iE”~~T‘+~I W’T’rx m”w,~‘~P,ww: F’.‘! iza?mr “---“xE-~~~3,~~ 11”19-F-s “57 3%!

Blood eosinophil and monocyte counts are related to smoking and lung function

E. Juel Jensen, B. Pedersen, E. Narvestadt & R. Dahl 63 I Texas ,ww,nm ?TS1Y~~~?;“I~~,~:‘~~~~,~‘~4EP’~I~”~‘CXlt IW + T”m*:I- ?a”, ?T m I-YT’W’rn~S + mimsPpu+ ‘rn~~~iv T-r?? ?~W7T~~jl3

Characteristics and complaints of patients prescribed long-term oxygen therapy in the Netherlands z * “..

M. J. Kampelmacher, R. G. van Kesteren, G. P. J. Alsbach, C. F. Melissant, H. J. Wynne, J. M. C. Douze & J-W. J. Lammers 70

~~~~~~~,~,,~~~~~ m -v-~~~r I, _m

The enhanced inflammatory response in non-small cell lung carcinoma is not reflected in the alveolar compartment

A. J. Staal-van den Brekel, M. A. Dentener, M. Drent, G. P. M. ten Velde, W. A: Buurman & E. F. M. Wouters 76 ~WC’iwinar’m? --n~m.w”swar, 1 - “mlw~~‘w~ ~~~‘+ag~~-~~filsrr‘Jix~~I~~~,~~~ ~al~~~~~~l~i:?‘*‘~~l~rrgp~,‘~ i?rf*m “n-m- 1

Do patients using long-term liquid oxygen differ from those on traditional treatment with oxygen concentrators and/or compressed gas cylinders? A comparison of two national registers

J. Schaanning, K. Stream & J. Boe

Differences in sensitivity, maximal response and position of the concentration-response curve to methacholine between asthmatics, patients with allergic rhinitis and healthy subjects

84

Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less

N. C. Barnes, C. Hallett & T. A. J. Harris 95 nwi

A comparison of the performance of two modern multidose dry powder asthma inhalers L. S. Hill & A. L. Slater

Is high-dose fluticasone propionate via a metered-dose inhaler and Volumatic@ as efficacious as nebulized budesonide in adult asthmatics?

J. F. O’Reilly, D. C. Weir, S. Banham, G. S. Basran, G. Boycl & K. R. Pate1 111

Case Reports A case of allergic bronchopulmonary aspergillosis successfully treated with itraconazole Y. Nikaido, N. Nagata, T. Yamamoto, C. Yoshii, H. Ohmor~i’& M. Kido 118

%

Pulmonary cryptococcoma with CD4 lymphocytopenia and meningitis in an HIV-negative patient C. L. Ho, B. C. Chang, G. C. Hsu & C. P. Wu

nmz

Reactive amyloidosis in a patient with Mycobacterium simiae pulmonary infection A. Aharon, P. Langevitz, R.

Number 2 February 1998

Editorial

Topical Reviews Sarcoidosis: historical perspective and immunopathogenesis (part I) G. Zissel & J. Miiller-Quernheim

Sarcoidosis: clinical manifestations, staging and therapy (part II)

126

Health habits and illness behaviour: social factors in patient self-management

Original Articles Ventilation in a Birmingham intensive care unit 1993,-1995: outcome for patients with chronic obstructive pulmonary disease r A. T. Hill, R. B. Hopkinson & D. E. Stableforth 156

%I

Budesonide but not terbutaline decreases phagocytosis in alveolar macrophages A. Zetterlund, P. H. Ldrsson, C. Mi.iller-Suur, L. Palmberg & K. Larsson 162

Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis

H. Yamanouchi, J. Fujita, T. Yoshinouchi, S. Hojo, T. Kamei, I. Yamadori, Y. Ohtsuki, N. Ueda & J. Takahara 273

The effect of oral corticosteroids on bronchodilator responses in COPD

2. Corden & P. J. Rees

Are symptoms of obstructive sleep apnoea syndrome related to bronchitic symptoms or lung function impairment? Report from

the Obstructive Lung Disease in Northern Sweden Study

279

283

Improving communication between hospital and primary care increases follow-up rates for asthmatic patients following casualty

attendance

P. H. Johnson, 1. Wilkinson, A. M. Sut A 289

A comparison of regular salmeterol vs ‘as required’ salbutamol therapy in asthmatic children Blic, M. la Rosa P.-H. Kaad & A. Moorat

One-year economic evaluation of intensive vs conventional patient education and su

patients

R. 00

Cold air inhalation and exercise-induced bronchoconstriction in relationship to metacholine bronchial responsiveness: different

patterns in asthmatic children and children with other chronic lung diseases

K-H. Carlsen, G. Engh, M. Merk & E. Schrmder 308

Asthma, type-l allergy and related conditions in 7- and g-year-old children inNorthern Sweden: prevalence rates and risk factor pattern

nsson ts-Mil 316 l,~%4BKCU WmzP

Safety and efficacy of a high cumulative dose of salbutamol inhaled via TurbuhalerO or via a pressurized metered-dose inhaler in

patients with asthma

E. Bondesson, K. Friberg, S. Soliman & C.-G. Lofdahl ~~~~~~~‘~~~,,~~~~~

325

Haemodynamic response during initiation of non-invasive positive pressure ventilation in COPD patients with acute ventilatory

failure

M. Confalonieri, P. Gazzaniga, L. Gandola, S. Aiolfi, R. Della Porta, A. Frisinghelli & A. Bellone 331 ~~~~~‘~~~~~~~~~~~~

Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis

A. Xaubet, C. Agusti, P. Luburich, J. A. Barber& M. Carrion, M. C. Ayuso, J. Rota & R. Rodriguez-Roisin lmmxw‘

338

Short Reports Time trends and seasonal variation in acute childhood asthma in tropical Singapore

F. T. Chew, D. Y. T. Goh, B. C. Ooi & B. W. Lee

Fluticasone propionate: an audit of outcomes and cost-effectiveness in primary care

J.

A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease

ZZO tera, F. Di Perna, ro, o & A. Vinciguerra !Bmxa ,~~~~~~~~~~~~~~~*~

Case Reports Apical pleural mass developing following talc pleurodesis

T.‘Williams, B. Gostelow, D. Woods & T. Spyt

Rhabdomyolysis and bacterial pneumonia

R. P. Byrd Jr & T. M. Roy

358

359

Number 3 March 1998

Topical Reviews

Prediction equations for forced spirometry from European origin populations

J. s, J. Sunyer, J. A. Barbers & J. Rota ems “9ww*R~~~7L(BUn~T’~mmw 1 z ‘“J‘“~,,,. ” ““~“I”I’f”‘l?i~~~~,~~~~~~g’c619%”~~~l,?n~r~~’,;~~‘~!~~rrIn~~~~~

The T cell receptor subsets of lymphocytes in bronchoalveolar lavage in patients with active pulmonary tuberculosis

S-T. Uh, S. Y. Ki, G-l. Lim, S. H. Moon, S. W. Jeong, H. T. Kim, Y. H. Kim & C. S. Park

S. L. Chisholm, F. W. Dekker, A. Knuistingh Neven & H. Petri 1 w~~~~i69u’i”~~iaR6~~,~~~~~ ~~s’~~.~m~r’~~~‘~~~~~‘inw,~‘ar.~-g-p “7 “~-“1”3”~ * a-mrrsm’v~‘men’.raa%mm% 7m!!wvs

Nocturnal oxygen and hypercapnic ventilatory response in patients with congestive heart failure

S. Andreas, F. van r Miihlen, J. Stevens % H. Kreuzer ‘n,- * w”q~r3 ~-‘&l’w--m+ni-mT

Pulse oximetry at fibre-optic bronchoscopy in local anaesthesia: indication for postbronchoscopy oxygen supplementation?

M. S. Kristensen, N. Milman & I-L. Jarnvig

421

426

432

Long-term mechanical ventilation in amyotrophic lateral sclerosis

J. Escarrabill, R. Estops, E. Farrero, C. Monasterio & F. Manresa i?9-wl!m~w’s’n_w ‘~,~~~~~~~~~~~,~~, 8:x”?&-“Bivi-l%l ?-a 7s As-2 Pmw-r ““19rPl-T-P -*“‘T*-:~mii‘-~~~~~~m~~

Effect of oral antibiotics on lung mucociliary clearance during exacerbation of chronic obstructive pulmonary disease

A. Hasani, D. Pavia, S. Rotondetto, S. W. Clarke, M. A. Spiteri & J. E. Agnew ~nb-lll~~~‘Ol~~~~,~~~~~~~‘“~ i’ wmF6 rn’mP‘I[TF = lwlg’,‘+“‘ilp7 ?“p 14.1 “XI :%“nn y”y ~~~~~~~~~~~~~~~~

Peripheral airways obstruction on high-resolution computed tomography in chronic severe asthma

D. H. Carr, S. Hibon, M. Rubens & K. F. Chung m-

Prediction equations for plethysmographic lung volumes J. Rota, F. Burgos, J. A. Barber&, J. Sunyer, R. Rodriguez-Roisin, J. Castellsague, J. Sanchis, J. M. Antbo, P. Casan & J. L. Clausen 454

Non-adrenergic, non-cholinergic function in the human airway

T. W. Mackay, G. Hulks & N. J. Douglas 461

The European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): recruitment methods and

strategies

stma, L. A. Laitinen, S. V. Ohl R. A. 467 imDFm

Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions

ng, Y.-M. Chen, M.-F K.-C. Chou,

Prevalence of bronchial hyper-responsiveness in the southern, central and northern parts of Sweden

n, P. e, E n, L. Rosenhal son

Diagnostic value of closed percutaneous pleural biopsy vs pleuroscopy in suspected malignant pleural effusion or tuberculous

pleurisy in a region with a high incidence of tuberculosis: a comparative, age-dependent study

A. Emad & G. R. Rezaian 466

Radiographic spectrum of adult pulmonary tuberculosis in a developed country

J. T. R. Wilcke, D. S. Askgaard, B. Nybo Jensen & M. Dessing 493

A comparison of different methods of spirometric measurement selection

H. Koyama, K. Nishimura, A. Ikeda, M. Tsukino & T. lzumi 498 rnrn$

Comparison of four types of portable peak flow meters (Mini-Wright, Assess, Pulmo-graph and Wright Pocket meters) ,m

H. Koyama, K. Nishimura, A. Ikeda, M. Tsukino & T. lzumi 505 &wBd&

N-Acetylcysteine inhibits IL-la-induced IL-8 secretion by bronchial epithelial cells

K. Matsumoto, S. Hashimoto, Y. Gon, T. Nakayama, H. Takizawa & T. Horie 512

Lung function in patients with inflammatory bowel disease

N. Tzanakis, D. Bouros, M. Samiou, P. Panagou, J. Mouzas, 0. Manousos & N. Siafakas 516 -m*am -Lam a

Long-term nasal intermittent positive pressure ventilation in patients with cystic fibrosis and hypercapnic respiratory failure

(1991-1996)

A. T. Hill, F. P. Eden

Predicting cognitive decline in pa , M. P. Torrice A. Gemma & R. Pistelli 7

%

Oxygen, arterial blood gases and ventilation are unchanged during dialysis in patients receiving pressure support ventilation

C.-C. Huan n, Y.-H. Tsai & T. C. Y. Tsao 534 Bcz

Prednisolone in acute childhood asthma: clinical responses to three dosages

S. .Langton Hewer, J. Hobbs, F. Reid & W. Lenne 541

Effect of nasal inflammation and of intranasal anti-inflammatory treatment on bronchial asthma

N. Mygind, R. Dahl & L. P. Nielsen 547

Leukocyte counts in hypertonic saline-induced sputum in subjects with occupational asthma

A. Di France, B. Vagaggini, E. Bacci, M. L. Bartoli, S. Cianchetti, S. Carnevali, F. L. Dente, D. Giannini, P. Macchioni, L. Ruocco & P. L. Paggiaro 550

‘~~~‘R~~~~~~~~~~~~~~-~.i?~~~(~

Number 4 April 1998

The use of home nebulizers in adult asthma

P. Demoly, D. Jaffuel, H. Sahla, J. Bousquet, F.-B. Michel & P. Godard

Original Articles

624

The measurement of the single-breath transfer factor for carbon monoxide and its components using the Morgan Transflow system

R. Carter, 0. A. Al-Rawas, R. D. Stevenson, S. K. Naik & D. J. Wheatley 628 ‘SrniE Bs!se

Curved chest tube for drainage of malignant pleural effusion

H. Ishikawa, H. Satoh, Y. T. Yamashita, H. Kamma, T. Naito, M. Ohtsuka & S. Hasegawa 633 m

Prescribing for persistent cough in children

A. Picciotto, M. Hubbard, P. Sturdy, J. Naish & S. A. McKenzie 638 mm

Variations in hospitalization rates for asthma among Black and minority ethnic communities

iffith 42 sm

HLA-DQBl and HLA-DPBl genotypes in familial sarcoidosis

M. Schiirmann, G. Bei Kirsten, M. Schlaak, J. Miiller-Quernheim & E. Sch 6

Improved lung function and quality of life following increased elastic recoil after lung volume reduction surgery in emphysema

M. Norman, G. Hillerdal, L. Orre, L. Jorfeldt, F. Larsen, K. Cederlund, G. Zetterberg & G. Unge 653

Closed percutaneous pleural brushing: a new method for diagnosis of malignant pleural effusions 1 A. Emad & G. R. Rezaian 659

Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease

D. Dev, E. Wallace, R. Sankaran, J. Cunniffe, J. R. W. Govan, C. G. Wathen & F. X. S. Emmanuel 664 .%z??

The role of self-treatment guidelines in self-management education for adult asthmatics

J. van der Palen, J. J. Klein, G. A. Zielhuis & C. L. A. Van Herwaarden ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ %9mmsx

Relationship between subjective fatigue and physiological variables in patients with chronic obstructive pulmonary disease

S. 0. Breukink, J. H. Strijbos, M. Koorn, G. H. Koeter, E. H. Breslin & C. P. van der Schans .‘

668

676

Long-term treatment of asthmatic patients with salmeterol YS slow-release theophylline

S. Nutini, T. Martini & R. Righi ~~~~~~~~~~,~~~~~~~~I

663

Short Report Finger clubbing in malignant mesothelioma and benign asbestos pleural disease

C. McGavin & P. Hughes

:i

691 aam

Case Reports Pneumonia caused by Pseudomonas putida with a mucoid phenotype

J. Fujita, K. Negayama, M. Ohara, S. Hojo, Y. Obayashi, H. Miyawaki, Y. Yamaji & J. Takahara

lemmLs:la

Lobectomy in cystic fibrosis

R. Bragonier, D. Grier, F. Carswell & S. Cunningham

Cardiac sarcoidosis: the value of magnetic resonance imaging in diagnosis and assessment of response to treatment

M. J. Doherty, S. Kishore Kumar, A. A. Nicholson & D. V. McGivern

693 %,

L 695

697

866~ hew s .wwd

Bilateral endobronchial metastases due to a chondroblastic osteosarcoma

M. J. Doherty, A. P. Campbell, M. E. Cowan & M. A. Greenstone

Response of dermatomyositis co-existing with non-small cell lung cancer to chemotherapy

K. W. T. Tsang, W-K. Lam & M. Ip

Lung abscess with squamous epithelial lining

786

788

K. E. Bendstrup, J. I. Jensen & I. Reintoft

Letters to the Editor

Epidemiologic studies of adult bronchial asthma in Turkey

. F. Kalyoncu, 2. T. k & L. Coplii

Reply to Drs Kalyoncu, Selcuk and @phi

Number 6 June 1998

Topical Review Leukotriene antagonism in asthma and rhinitis

S. J. Lane

Original Articles

Total respiratory system compliance after thoracoplasty

K. Shiraishi, H. Sasaki, M. Yaekashiwa, M. Motomiya & T. Nukiwa T-m?

810

Rapid diagnosis of smear-negative pulmonary tuberculosis via fibreoptic bronchoscopy: utility of polymerase chain reaction in

bronchial aspirates as an adjunct to transbronchial biopsies

. Yew, C. Y. Chan, L. Y. Au, S. W. Cheung & A. F. 6. Cheng E~~~llm,CT”~~“‘~~~~~~~~~~~~.‘~~,~~ ‘~‘~~~~~~~~~~~~‘,~~~ o~~i~g;n$s~~iccxB’~~,~~~~~,~~-~~~,~~~~

Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two

centre study

Picca, R. Sabato, M. Rizzi, F. Scarpelli & M. Sergi

815

Tension-time index of inspiratory muscles in COPD patients: role of airway obstruction

yot, P. F. Perrigault, V. Gautier-Dechaud, X. Capdevila, J. Milic-Emili, Ch. Prefaut & M. Ramonatxo 828 ;~~~~Bilki~~~~“~,i911”~“~~~~~j~~~~~~~~~~,~,~~~~~~~~,~,~~~~~~~,~,~~~~~~~~~~,~~,~,~~~~~~~~~~~~~~~~~~~~~,~~~~~~~~~

A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease

D. Vervloet, T. Ekstrom, R. Pela, F. Duce Gracia, C. Kopp, 8. D. Silvert, E. Quebe-Fehling, G. Della Cioppa & G. Di Benedetto 836

Comparison of the severity of sleep-disordered breathing in Asian and Caucasian patients seen at a sleep disorders center

K. C. Ong & A. A. Clerk 843

Symptoms and pulmonary function in asthma

S. M. Alcock, M. Mamun, R. J. Prescott & C. K. Connolly 849 ~~~~~~~~~~~~,~~~ ma&%&E~mLBrarL L 1 _I - masji; ip’~l~~~~~~~~~~.l$i:F~~~“‘~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~,~~~~~~~~~~~~.~~~~“~~~~~~~.~~~~~~~~~~~

Case Reports

Multiple drug-resistant Nocardia ustevoides isolated from a patient with pulmonarynocardiosis

H. Shishido, K. Deguchi, S. Miyake, S. Akagawa & Y. Yoshizawa .$ ‘q,-(f??#l”n “#‘“” yyI i “‘““*“y 2’ -3 :xX”% :m. L ,‘8?. k ,‘a : : **” 4 ^*lmfA .‘x”S r*~~~%:P’~IPfi’~:il; ga,it w,mps. ?w- :-Ei”~74?~rxz

Chest CT scanning: utility in lung endometriosis

873

R. Orriols, X. Muiioz, A. Alvarez & G. Sampol

Solitary columnar bronchial papilloma: a rare endoscopic finding

M. Henry, R. L F. Kealy & C. P. Bre 1 -mw= lWT*“WWW, ‘!F =-$?I, _

Thymic carcinoid with mutinous stroma: a case report

T. Ohchi, H. Tanaka, Y. Shibuya, T. Shibusa, M. Inuzuka, M. Satoh & S. Abe ,:~~.~ri31”P’rB!T+~~~~~~~‘~~~~~r?-9~”f’~iiPCn~~~~“~~~~~~~~~,~~~~~~.~~~~~~~~~.~~~~~~~~~, i i,n. i

Primary mediastinal nonseminomatous germ cell tumour in an adult female

Y. Morishima, H. Satoh, M. Ohtsuka, T. Yazawa, Y. Yamashita & S. Hase mrw9w -RYEma .~Tx~8~ ~mv~‘!aKTs-rn,h., --w-La, a. --“-c‘3~,~~‘?E’1~~~~,~.~~~~~~~~~~ ,#lewAFmmm

Idiopathic bronchiolitis obliterans with organizing pneumonia presenting with adult respiratory distress syndrome

L. A. Perez de Llano J. L. Soilan, M. J. Garcia Pais, I. Mata, M. Moreda & B. Laserna TIs~~?E’~“~EG:*$“~~~~‘~~~~.~~ BL G-8 t 11 -‘-~-%!xwE~ I wlT”‘ci32m? T 3%w2~‘rL”?a~%~ ,iM+sn5”“l”lp-i

Diffuse pulmonary ossi n and recurrent spontaneous pneumothorax in a patient with bronchial asthma

Y. ikeda, H. Yamashita & T. Tamura

Pleomorphic adenoma and severe tracheal obstruction

J. Pomp. B. J. M. Pannekoek & S. H. Overdiep

Appearance of central apnoea in a patient treated by auto-CPAP and obstructive sleep apnoea

A. Boudewyns, P. Van de Heyning & W. De Backer 3,“: / ., r~~‘l~nR,~~~~~~~~~~‘~I-l^iCln‘~~l~~’~~~(iil~~‘ll^~~~8 ‘c-% nrc: si”vw, zEm-xTa-3mmm?.T’

884

887

889

891

Number 7 July 1998

Topical Reviews

Interrelationship between pharmacokinetics and pharmacodynamics in choosing the appropriate antibiotic and the dosage regimen

for treating acute exacerbations of chronic bronchitis

M. Cazzola & M. G. Matera ‘i ;Il”%s ~W ,-1”1’1 i ,T”.X

895

Original Articles Exhaled nitric oxide; relationship to clinicophysiological markers of asthma severity

M. K. AI-Ali, C. Eames & P. H. Howarth 908

Spirometric reference equations for older adults W. F. McDonnell, P. L. Enright, D. E. Abbey, S. F. Knutsen, J. A. Peters, R. J. Burchette 8. M. D. Lebowitz

Cigarette smoking decreases interleukin-8 secretion by human alveolar macrophages T. Ohta, N. Yamashita, M. Maruyatih, E. Sugiyama & M. Kobayashi

The role of domestic factors and day-care attendance on lung function of primary school children K. Demissie, P. Ernst, L. Joseph & M. R. Becklake ,. 928 / ‘~B#ba

Time course of respiratory decompensation in chronic obstructive pulmonary disease: a prospective, double-blind, study of peak flow changes prior to emergency department visits

G. H. Murata C. 0. Ka wm”PiQ

methasone dipropionate on bronchial mucosa and asthma symptoms in patients with atopic asthma

M. Hoshino, Y. Nakamura, J. J. Sim & H. Tomioka 942

Effect of hyperoxia on human macrophage cytokine response V. Cazals & A. Clement 951

Short Technical Note

Drainage of spontaneous pneumothorax using an intravenous catheter. Immediate and long-term results E. Maury, F. Doyon, B. Guidet, A. Moty & G. Offenstadt 961

Case Reports

Broncholithiasis: rare but still present A. S. Nollet, J. F. Vansteenkiste & M. G. Demedts

A case of lymphomatoid granulomatosis mimicking sarcoidosis

963

ice

Salmonella empyema following splenic biopsy

Pulmonary infarction revealing pulmonary Takayasu’s arteritis G M. Iiii ‘aa#aa

Invasive pulmonary aspergillosis in an insulin-dependent diabetic S. M. Janes K. F. Barker V. Mak

Y. Suzuki S. Suzuki M. Numata Y. Matsumoto J. Suzuki, H. lkeda & T. Okubo

Diagnosis of pulmonary veno-occlusive disease: new criteria for biopsy L. Valdes, J. R. Gonzalez-Juanatey, D. Alvarez, J. Antunez, J. Manuel Valle, P. Penela & R. Alvarez-Sala 979 wr

Transient cortical blindness: a complication of bronchial artery embolization S.-F. Liu, T-Y. Lee, S.-L. Wong, Y.-F. Lai &A.-S. Lin

Pulmonary vasculitis associated with anti-Jo-l antibodies

983

I. Brown, C. Joyce, P. G. Hogan, J. Armstrong, R. Steele & A. S. Bansal 986

Number 8 August 1998

Original Articles An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD

N. Yasuda, K. Gotoh, S. Minatoguchi, K. Asano, K. Nishigaki, M. Nomura, A. Ohno, M. Watanabe, H. Sane, H. Kumada, T. Sawa & H. Fujiwara 993 i ,I’*“. s. X’lBI” g,q,er;“:i n q.~,~““X”-g, pp,a rq /’ E+T-hETI f -qlwrr I,,Bvy.“TW’S IIWP +“Z:‘r ,pw VW x mm U’CSCrl @MS I i I’ i ,“’ A!81 i: f.& ‘m’“1mb+ ‘V -* ?#:1*-’ $‘?. g s,*,‘ -a&, =**a-*‘.&$ * 52; i”

Starting home nebulizer therapy: patients’ expectations and subsequent outcome at 2 months

A. J. Simpson, P. M. Tweeddale & G. K. Crompton 1000

Hospitalization for lung disease in early childhood and asthma symptoms in young adulthood

C. Svanes, E. Omenaas, G. E. Eide, 0. Fluge & A. Gulsvik 1003 i ill”-: xgv-e-m!.? v-~~~“~” P Wl”P”~~ tw=%-w~r r ~Fisiur~vP “l”l(‘I i ‘” I VW.2 ‘CXC 1 ll’ l i “VT ‘pm B’“3r-f -p”vaFs!! #-?m,@lrw rq~%mwnjw .vpn ,a, met” J~Ppppv~ ##p i g -‘, - 2 ‘““t *im,m.t yqv=m,1: *clTamp*$,-q

A double-blind placebo-controlled study of the effect of influenza vaccination on airway responsiveness in asthma

D. W. Reid, C. L. Bromly, S. C. Stenton, D. J. Hendrick & S. J. Bourke 1010 1 a’-% XI”.~.‘UarXu?;7~iSE~~~~~~~~~~IC~~‘L!i99,ffl””i~, f rml’ %:-UT g 6W s P., i ‘;b.ilp’, “,k9Bi$?’ p#~&‘x~g ,E! “iQ”mlf n~t~‘YwTS‘?-” “ID - z?!!mK3 ‘I% “mm %mPa’xm?3L” rw’~,~~~~~~~~~~~,, ~Bn~~imiTJlli

Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive puhnonary

disease

(IL-lra) in peripheral blood

Z. Wang, A. Mann en, P. Malmberg & K. Larsson

Does the number of hypopnoeas influence therapy in patients with obstructive sleep apnoea?

M. Carrera, F. Barb6 & A. G. N. Agusti j~~,b?RxJ’BQ n^isam-Q& e.~“X’*~~,~ran’-iril* := n_ *, (_, “a~,--,~‘“iI-Iwil~,~~~,~~‘~~~‘~

Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy; clinical outcomes, and cost

1028

analysis

1032

1040

1046

The cardiorespiratory response to submaximal exercise in subjects with asthma following pretreatment with controlled release oral

salbutamol and high-dose inhaled salmeterol

S. M. Revill & M. D. L. Morgan 1053 Jim

S. D. Aaron R. E. Dales & B. Pham 1059 JwE*~ra mkn

Change in anaesthesia practice and postoperative sedation shortens ICU and hospital length of stay following coronary artery

bypass surgery

An Ds an0 1 %immi.

Is gastro-oesophageal reflux a factor in exercise-induced asthma?

rnberg D. Zarnir 2. Fireman

G. Liistro, P. Rombaux, M. Dury, T. Pieters, G. Aubert & D. 0. Rodenstein 1076

Case Reports Pulmonary mycetoma probably due to Cundida albicans with complete resolution

A. T. Abel, S. Parwer & S. C. Sanyal

Migratory pulmonary infiltrates

M. C. Rodriguez, M. Capurro, F. Gomez & M. D. Ludefia 1081 I mml?xI

A case of diffuse panbronchiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D,/E, receptor antagonist

M. Abe, S. Hashimoto & H. Hara 1084 I'm

Unique pulmonary presentation of intravascular large cell lymphoma

s, ns'%xT

1087

Pulmonary veno-occlusive disease complicating Felty’s syndrome

x, M. 1089

Number9September1998

Original Articles Increase in non-specific bronchial hyperresponsiveness without specific response to isocyanate in isocyanate-induced asthma:

a pilot study

M. C. Kopferschmitt-Kubler, N. Frossard, G. Rohde & G. Pauli 1093

T. E. Hallas 1099

Glucocorticoid receptor mRNA levels in bronchial epithelial cells of patients with COPD: Influence of glucocorticoids

S. H. Korn, F. B. J. M. Thunnissen, G. J. Wesseling, J.-W. Arends & E. F. M. Wouters 1102 m?w I

The Scottish multi-centre prospective study of bronchoscopy for bronchial carcinoma and suggested audit standards

A. N. McLean, P. d’A. Semple, D. H. Franklin, G. Petrie, E. A. Millar & J. G. Douglas 1110

Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease

D. Patakas, D. Andreadis, E. Mavrofridis & P. Argyropoulou 1116

Short Communication

Case Reports

Number 10 October 1998

Single centre open study to compare patient recording of PRN salbutamol use on a daily diary card with actual use as recorded by the MD1 compliance monitor

S. Hamid, J. Kumaradevan & G. M. Cochrane 1188

Exercise training improves recovery in patients with COPD after an acute exacerbation

The use of a neural network for studying the relationship between air pollution and asthma-related emergency room visits A. Nutman, Y. Solomon, S. Mendel, J. Nutman, E. Hines, M. Topilsky & S. Kivity 1199

)Iaa

Improvement in patient compliance with long-term oxygen therapy following formal assessment with training D. G. Peckham, K. McGibbon, J. Tonkinson, G. Plimbley & C. Pantin 1203

Asthma health status measurement in clinical practice: validity of a new short and simple instrument E. A. Barley, F. H. Quirk & P. W. Jones 1207

Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation E. Clini, C. Sturani, R. Porta, C. Scarduelli, V. Galavotti, M. Vitacca & N. Ambrosino 1215

Mild experimental exacerbation of asthma induced by individualised low-dose repeated allergen exposure. A double-blind evaluation

K. n,

Quality of life in elderly patients with COPD: measurement and predictive factors A r.s!ji’

Consistent effects of high socioeconomic status and low birth order, and the modifying effect of maternal smoking on the risk of allergic disease during childhood

S. A. Lewis & J. R. Britton 1237

Pulmonary function threshold for distinguishing ventilatory- and nonventilatroy-limited patients with airflow obstruction G. Fink, J. Lebzelter, D. Turner, E. Klainman, M. Shlomo, I. Katz, M. Kramer & S. Spitzer 1245

Case Reports Gastroesophageal reflux presented with haemoptysis and carinal erythematous lesion resembling in situ carcinoma D. Bouros, N. Tzanakis, K. Psathakis, G. Patsourakis & T. Rokkas 1251

Pulmonary Langerhans’ cell histiocytosis following autologous haemopoietic progenitor cell transplantation N. Soler, J. A. Barber&, J. Ramirez, M. Batlle, C. Rozman & R. Rodriguez-Roisin 1252

Letters to the Editor Survival experience of the population needing hospital treatment for asthma or COPD at the age of 50-54 years 0. M. P. Jolobe 1256

Careful consideration needed with diagnoses of heart disease in COPD patients T. Keistinen & T. Tuuponen 1256 I,

Number 11 November 1998

Topical Review

Are anti-oxidant and anti-inflammatory treatments effective in different subgroups of COPD? A hypothesis

C. P. van Schayck, P. N. R. Dekhuijzen, W. J. M. J. Gorge@, P. M. van Grunsven, J. Molema, C. L. A. van Herwaarden & C. van Wee1 ,:*:vii “?mm”‘# !I$ ma17 Tmm,m “W la, -“-3mm-na.pWla ~~~~~~~~~~~~~~~~ m”~-Tr”w-slm *

Original Articles

Screening patients in general practice with COPD for long term domiciliary oxygen requirement using pulse oximetry

C. M. Roberts, J. Franklin, A. O’Neill, R. P. L. Roberts, J. Ide, M. L. Hanley & J. Edwards 3 r 11 E-3 ~‘WPB, tt-- IT QZ E- wrz t-z ‘I”fbP~~~%“,~~.*1114‘:‘ :: qxwB’Tq 7 32 ~‘sg”s!Frw~~p:p _ ‘WV3 ‘ICIE I ‘“rr-wmwz W’MG Em’?* 3”~‘Fmtl~~~~~~~~~~~~~~~

Pneumothorax in active pulmonary tuberculosis: resurgence of an old complication?

J. Blanco-Perez, J. Bordbn, Piiieiro-Amigo, R. Rota-Serrano, R. lzquierdo & J. Abal-Arca TV” .~d4~“xs”,~,s1”~~~~~‘~,~~~~~~~ +m%s-La.Tp- lw%wwPm.* ‘FE-a *I”‘“~~~S,~.~?~,~~~~~~‘~~~~ Y . ,,,

The Darlington and Northallerton Prospective Asthma Study: best function predicts mortality during the first 10 years

6. K. C M. M , S. M. Alcock & J. Prescott i’m’mrw Van? ??a- f-~~P~mw’:~,-~~

Verification of self-reported asthma and allergy in subjects and their family members volunteering for gene mapping studies

P. Kauppi, L. A. en, H. aitinen, J. Kere & T. Laitinen ! 3&mm J-vLlwWiiw Tw?p za”‘ir” m~~m”li”.x ~ml~.zvmaxEm~hg”: stm~?‘n~-rPwTr, I- _ ~~“~~~~~,~~~~~~~~ !EWT%?lZWmW

The management of pulmonary tuberculosis in adults notified in Scotland in 1993

A. J. Simpson, B. att, S. H. Heald, M. F. Sudlow & A. G. Leitch r”Fmm~m Fs!wtT% -Pmrminmv Tz rn!am “~l”-~F”rr+ji~~~,‘~‘~~~~ .Jwm!!tE m-wm-~ ;I”-l?fc%wE?T

Interstitial lung diseas systemic sclerosis: comparison of BALF lymphocyte

J. Domagata-Kulawik, G. Hoser, A. Doboszyhska, J. Kawiak & W. Droszcz C’! &‘,LCi’@r” a “~liprs~~~ ‘“!p!B” 3 m,n 2 / ‘I* ‘iqrr.3 85% %& ~w#‘i-I* “21yp?il’~xwm lr “Fl’X p:;cr3nT,~*?“~ T,P”I -ai. = ,,a i . n~.Fy-r’~~~.~M~~-i-‘~~-FtX”:,l~’ IXzaF

Short Report

1265

89 mm

1295

1302

A.1

Number 12 December 1998

Original Articles

Genetic polymorphism of the angiotensin-converting enzyme (ACE) in asthmatic patients

H. Tomita, S. SatO, R. Matsuda, N. Ogisu, T. Mori, T. Niimi & S. Shimizu 1305 “v-v 4 w “T”-n wr;inrln% 9-T **81*?i ‘V”‘-B -m?8wa *‘Tms”*k T,‘~T”B7pT~“lp~“‘p m”1” qy-rrq “6-aT1Q”~ mxrmw”““i ,lFw” -““i?“r-P11vil’? ‘I;: *.a’i - m- ‘“-7,x wv”~**r2 *” 1 p’sz ivm@

Non-invasive home ventilation in patients over 75 years of age: tolerance, compliance, and impact on quality of life

J.-P. Janssens, E. Cicotti, J.-W. Fitting & T. Rochat 1311 :p ~-hww’*lli s&qw 5 zt+ /‘B,‘liu~“ll~~,~~~~-~‘~~,~,,~~,‘~,!,~~’.~~~,~~ j Tw* =m”qTggo%~>-si .==‘,a- xrviP~m!‘l&“:.Yz‘T “F ~blfW~~ 1 ~!P~mR~wL~-m Ew*r *wrwm;U”e ‘rc!m Ct”FI 41’

Effects of severity of long-standing congestive heart failure on pulmonary function

I. Dimopoulou, M. Daganou, 0. K. Tsintzas & G. E. Tzelepis wa”iB ,vxPmi “FTmx?“‘F^“W - 2, W” 8, f-‘-a ‘“ipm?‘li (f-7 a7 i”T“prpiv%“q,~~:~@ ix T-w”m~~ ‘: *-‘1”“-* Iri- -,g-qppibw ry ‘prmxywmm‘ir Z3r.‘“1 ,G*~~lxiixsi‘~%~ m2lys 3

Different expression of integrins by mononuclear phagocytes in peripheral blood and bronchoalveolar lavage fluid

I. StN% H. Pokornd, L. Zheng, J. Guzman & U. Costabel 1326 “;‘~rF%‘?B,:,“+?s-,1,8 ]‘+‘!w:x’* 171 1?1 .*: p i,?i’?l”a”~- “i ) =* “2”‘:: :‘: I M”tM IT1)*ll,& “y- ?lua.gx”“~*r-l a ri*r ,qli- W”B s s,; I _ I__ ‘, U”“n- -wqyi7m yw*?@;8y:e*qm 7: zt”*?? ,,,*b ,a “p’* g,~se~7jj

Effects of hypoxia on renal hormonal balance in normal subjects and in patients with COPD

K. M. Skwarski, D. Morrison, A. Barratt, M. Lee & W. MacNee ?rm?% .ammP “w’~:PwrsPn~i~-. “-“,xT%r?3m~~v~ wmll ~?i~~.~~~“l7r”Qn~,,l-~~~~~,~ r:s-: ‘P~“~En!mw~X

Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden P. Montnemery, E. Adelroth, K. Heuman, A. Johannisson, S.-A. Johansson, L.-H. Lindholm, B. Lundback & C.-G. LBfdahl 1337

A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction J. A. van Noord, J. J. Smeets & F. P. V. Maesen 1346

Asthma-related prescribing patterns with four different corticosteroid inhaler devices G. D. Frost, A. Penrose, J. Hall 2% D. I. MacKenzie 1352

88

Effect of single doses of inhaled lignocaine on FEV, and bronchial reactivity in asthma T. W. Harrison & A. E. Tattersfield 1359

Case Reports Pulmonary adenomatoid malformation presenting as unilobar cysts in an adult D. Hellmuth, J. C. Glerant, H. Sevestre, A. Remond & V. Jounieaux 1364

L

Hypersensitivity pneumonitis probably caused by cyclosporine. A case report

Alglucerase treatment of type 1 Gaucher disease with pulmonary involvement 1370

1373

Supplement A June 1998

Foreword R. Dahl 1

Improved delivery of inhaled steroids to the large and small airways C. L. Leach 3

“II Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics J. P. Seale & L. I. Harrison 9

_i

Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 ug day -r delivered as an extrafine aerosol in adults with moderate asthma

17

Hydrofiuoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose

P. J. Thompson, R. J. Davies, W. F. young, A. B. Grossman & D. Donnell

Supplement B July 1998

Subject Index

Editorials, Letters to the Editor, Case Reports and Short Reports are indicated by (E), (L), (CR) and (SR) after the page numbers, respectively. S.A. = Supplement A; S.B. = Supplement B : I

A-a gradient value in asthma, bronchoalveolar lavage effects on 191-7

N-acetylcysteine characterization in anti-oxidant therapy 609-23 inhibition of IL-la-induced IL-8 secretion by bronchial

epithelial cells 512-15 acetylsalicylic acid-induced asthma, inhalation challenge

378-84 acupuncture in treatment of stable asthma 1143-5 adenoma, pleomorphic, and severe tracheal obstruction

889291 (CR) adrenal’ function, effects of beclomethasone dipropionate

compared with budesonide (S.B.) 2-45 adult respiratory distress syndrome, idiopathic bronchiolitis

ob;literans with pneumonia 884-6 (CR) aerosol, hypo-osmolar, induction of hyperventilation in

chronic non-asthmatic rhinitics 9-13 air pollution and asthma-related emergency visits, neural

network study of relationship between 1199-202 airways

pon-adrenergic, non-cholinergic function 461-6 obstruction, chronic upper, pulmonary edema following

1174-6 (CR) responsiveness, effect of influenza vaccination in asthma

1010-l 1 see also chronic obstructive airways disease; obstructive

airways disease; peripheral airways alglucerase treatment of type 1 Gaucher disease with pul-

monary involvement 1370-2 (CR) allergen exposure, low-dose repeated, to induce experimen-

tal exacerbation of asthma 1223-30 allergic bronchopulmonary aspergillosis therapy with itra-

conazole 118-19 CR) allergic rhinitis

effect of topical steroids on nasal nitric oxide production 558-61

methacholine response characteristics 88-94 allergy

in childhood, effect of socioeconomic status, birth order and maternal smoking on 1237-44

self-reported, gene mapping in families 1281-8 type 1, and asthma in Swedish children 316-24

alpha-1-antitrypsin deficiency national registry in Spain 118 l-7 PiSZ, geographical distribution in Europe 361-77 risk

factor in pulmonary emphysema 241-5 alveolar compartment non-involvement in inflammatory

response in non-small cell lung cancer 76-83 alveolar macrophages

budesonide and terbutaline effects on phagocytosis 162-6 in sarcoidosis 126-39 smoking and interleukin-8 secretion by 922-7

alveolitis evaluation by IL-8 in BAL cells in idiopathic pulmonary

fibrosis 33844 parasitic l-3

ambroxol characterization in anti-oxidant therapy 609-23 amyloidosis, reactive, in Mycobacterium simiae pulmonary

infection 1234 (CR) anaesthesia

local, pulse oximetry at fibreoptic bronchoscopy 532-7 and sedation practice in coronary artery bypass surgery,

ICU and hospital stay length and 1066-70 angiotensin-converting enzyme genetic polymorphism in

asthma 1305-10 anti-inflammatory

effect in COPD subgroups 1259-64 treatment effect on bronchial asthma 547-9

anti-Jo-l antibodies, pulmonary vasculitis with 986-8 (CR) anti-oxidant therapy 609-23

effect in COPD subgroups 1259-64 antibiotics effect on lung mucociliary clearance during

COPD exacerbation 442-7 arterial blood gases during dialysis in pressure support

ventilation 53440 asbestos pleural disease, benign, finger clubbing in 691-2

(SW aspergillosis

allergic bronchopulmonary, therapy with itraconazole 118-19

pulmonary, in insulin-dependent diabetic 972-5 (CR) Assess peak flow meter 505-l 1 asthma

ACE genetic polymorphism 1305-10 acute childhood, prednisolone in 541-6 acute severe, treated by mechanical ventilation 716-21 ASA-induced, inhalation challenge 378-84 beclomethasone dipropionate comparison with budeso-

nide (S.B.) 2-45 delivery improvement with hydrofluoroalkane-134a

(S.A.) 3-39 best function prediction of mortality 1274-80 beta,-agonists in dry powder inhaler 167-72 bronchial, diffuse pulmonary ossification and recurrent

spontaneous pneumothorax 887-9 (CR) epidemiology in Turkey 792-3 (L) nasal inflammation and anti-inflammation treatment

effects 547-9 bronchoalveolar lavage effects on PaO,, A-a gradient

value and bronchoconstriction 191-7 bronchoconstriction in relation to methacholine bron-

chial responsiveness in 308-l 5 budesonide as nebulizer suspension vs metered dose

inhaler 44-49 once-daily 421-5

cardiorespiratory response to submaximal exercise following salbutamol and salmeterol 1053-8

in children, salmeterol vs ‘as required’ salbutamol 292-9 chronic severe, peripheral airways obstruction on CT

448-53 clinic, nurse-run 26447 corticosteroids pharmacology 385-94

diagnosis, rapid dosimetric methacholine challenge 32-39 in elderly 513-7 evaluation of electronic hand-held spirometer 117780 exercise-induced, gastro-oesophageal reflux and 1071-5 experimental exacerbation following low-dose repeated

allergen exposure 1223-30 fluticasone propionate therapy 95-104 follow-up rates following casualty attendance, hospital-

primary care communication and 289-91 formoterol vs salbutamol onset of action in reversing

methacholine-induced bronchoconstriction 1346651 gas compression profile during forced expiration in 173-7 guidelines 1046652 health status measurement 1207-14 home nebulizers for adults 624-7 hospitalisation rates in Black and ethnic minority com-

munities 642-8 survival of middle-age patients 1256 (L)

influenza vaccination effect on airway responsiveness in 1010~11

inhaler comparison 105510, 11 l-17 intensive vs conventional patient education and super-

vision for self-management 300-7 leukotriene antagonism in 7955809 lignocaine inhalation effect on FEV, and bronchial

reactivity in 1359-63 long-term therapy with salmeterol vs slow-release

theophylline 683-90 methacholine response characteristics 88-94 nebulizer therapy at home 1000-2 non-adrenergic, non-cholinergic function of airways

461-6 I_

occupation, leukocyte counts in sputum 550-7 parallels with parasitic alveolitis l-3 pulmonary function and symptoms 849-57 recent-onset, work ability 729-34 -related emergency visits and air pollution, neural net-

work study of relationship between 11999202 -related prescribing patterns with corticosteroid inhaler

devices 1352-8 salbutamol via Turbohaler vs metered-dose inhaler in

325-30 salmeterol trials 777-82 , salmeterol vs theophylline 256-63 salmeterol xinafoate 13024 (SR) selfireported, gene mapping in families 1281-8 self-treatment guidelines for adults 668-75 severity marker relationship to exhaled nitric oxide

908-13 stable, acupuncture treatment 1143-5 steroid-dependent, management with methotrexate

1059-65 survival in hospitalized population 568-72 symptoms, ketotifen vs disodium cromoglycate and

beclomethasone dipropionate effects on 942-50 in Turkish children 203-7 in young adulthood 100339

time trends and seasonal variation in tropical Singapore 345-50 (SR)

type-l allergy and related condition in Swedish children 316-24

beclomethasone dipropionate comparison with budesonide (S.B.) 245

delivery improvement with hydrofluoroalkane-134a (S.A.) 3-39

vs ketotifen and disodium cromoglycate efIects on bronchial mucosa and asthma symptoms 942-50

beta,-agonists in dry powder inhaler for acute asthma 167-72

BIPAP device for obstructive sleep apnoea syndrome 820-7 birth order and maternal smoking effect on childhood

allergy 123744 blindness from bronchial artery embolization 983-6 (CR) blood

eosinophil and monocyte counts reiated to smoking and lung function 63-69

gases in non-smoking women with chronic liver disease 57-62

transcutaneous monitoring 584-7 bone, effects of beclomethasone dipropionate comparison

with budesonide (S.B.) 2245 Book Reviews

Clinical and biological basis of lung cancer prevention 1373 Peak flow nzeasurenzent. An illustrated guide 365

Breathe Right@ effects on snoring 107668 breathing, sleep-disordered, comparison in Asians and

Caucasians 843-8 breathlessness in COPD; salmeterol vs ipratropium bro-

mide effects on 1116-21 British Asthma Guidelines 1046-52 bromocriptine, pleuropulmonary disease as side-effect of

treatment with 11724 (CR) bronchial artery embolization, cortical blindness from

983-6 (CR) bronchial

aspirates and transbronchial biopsies, PCR for diagnosis of smear-negative pulmonary TB 815-19

carcinoma: bronchoscopy and audit standards 11 lo-15 epithelial cells, glucocorticoid receptor mRNA levels in

COPD, role of glucocorticoids 1102-9 N-acetylcystein inhibition of IL-la-induced IL-8 secre-

tion by 512-15 epithelium, neutrophils infiltrating in COPD 863370 hyperreactivity related to nitric oxide exhalation 908813

in Sweden 480-7 without specific response to isocyanate in isocyanate-

induced asthma 109338 metastases in chondroblastic osteosarcoma 786-8 (CR) mucosa, ketotifen vs disodium cromoglycate and beclom-

ethasone dipropionate effects on 942-50 papilloma, solitary columnar 878-9 (CR) reactivity in asthma, lignocaine inhalation effect on

1359-63 bronchiolitis obliterans, idiopathic, with pneumonia in

adult respiratory distress syndrome 884-6 (CR) bronchitic symptoms, obstructive sleep apnoea syndrome

symptoms related to 283-8 bronchitis

acute, von Willebrand factor antigen plasma levels 395- 400

chronic, antibiotic choice and dosage regimen for exacerbations 8955901

bronchoalveolar lavage cells, in eosinophilic pneumonia 743-9

interleukin-8 expression to evaluate alveolitis in idiopathic pulmonary fibrosis 338-44

lavage effects on PaO,, A-a gradient value and bronchoconstriction in asthma 191-7

fluid, hepatocyte growth factor measurement in pulmonary fibrosis 273-8

fluid, integrin expressions by mononuclear phagocytes in 1326-30

fluid, in lung cancer, cytokine fragment 19 as diagnostic marker in 766-71

fluid, lymphocyte phenotype compared to DLCO impairment in systemic sclerosis 1295301

T cell receptor subsets of lymphocytes in pulmonary TB 408-14

bronchoconstriction in asthma, bronchoalveolar lavage effects on 191-7 methacholine-induced, salbutamol vs formoterol onset of

action in reversing 1346-51 in relation to methacholine bronchial responsiveness in

asthma 308-15 bronchodilation prediction and salbutamol early reversibil-

ity after salmeterol in COPD 1012-16 broncholithiasis 963-5 (CR) bronchoscopy

for bronchial carcinoma and audit standards 11 lo-15 changes in oxygen saturation and transcutaneous carbon

dioxide and oxygen levels during 73942 fibreoptic, for diagnosis of smear-negative pulmonary TB

815-19 lignocaine and monoethylglycinexylidide levels during

4043 pulse oximetry in local anaesthesia 532-7

budesonide in asthma, nebulizer suspension vs metered dose inhaler

4449 comparison with beclomethasone dipropionate (S.B.)

245 effects on phagocytosis in alveolar macrophages 162-6 nebulized, vs fluticasone propionate delivery via inhaler

and Volumatic 11 l-17 once-daily in asthma 421-5

Burkholderia cepacia transmission and prevalence in cystic fibrosis 178-83

C-reactive protein measurements in COPD 6647 Candida albicans, pulmonary mycetoma from 1079980

(CR) carbon monoxide level measurement with single-breath

transfer factor 628-32 carcinoid, thymic, with mutinous stroma 880-J (C’R) cardiac

sarcoidosis, MRI imaging 697-9 (CR) surgery, positive end-expiratory pressure effect 858-62

cardiorespiratory response to submaximal exercise following salbutamol and salmeterol in asthma 1053-8

cat, effect on lung function in primary school children 928835

cataract formation, effects of beclomethasone dipropionate comparison with budesonide (S.B.) 245

CD4 lymphocytopenia and meningitis with pulmonary cryptococcoma in HIV-negative patient 120-2 (CR)

CD4’ T-lymphocytopenia, miliary TB causing acute respiratory failure in 977-9 (CR)

cefamandol, early transition to oral therapy in community- acquired pneumonia 1032-9

chest CT scans in lung endometriosis 87667 (CR) radiography and TB case-finding in Australia 198-202 tube, curved 633-7

cholesterol levels to distinguish transudates from exudates 762-5

chronic obstructive pulmonary disease (COPD) anti-oxidant and anti-inflammatory effects in subgroups

1259-64 C-reactive protein measurements 6647 corticosteroid treatment during oxygen therapy 50-56 EUROSCOP study 457-72 exacerbation, antibiotics effect on lung mucociliary clear-

ance during 442-7 exercise test duration and dyspnea recovery time, effects

of oxygen breathing and repeat testing 735-8 training and recovery after exacerbation 1191-8

Fas levels 993-9 FEV, value in screening for PaO, ~7.3 kPa in patients

qualifying for long term 0, therapy 1122-6 glucocorticoid receptor mRNA levels in bronchial epi-

thelial cells, effect of glucocorticoids 1102-9 heart disease and 125667 (L) hospitalisation, survival of middle-age patients 1256 (L) hypoxia effect on renal hormonal balance in 1331-6 nebulizer therapy at home 1000-2 neutrophils infiltrating bronchial epithelium in 863370 NPPV and haemodynamic responses 331-7 oral corticosteroid effects on bronchodilator responses

279-82 outcome following nocturnal non-invasive mechanical

ventilation 1215-22 predicting cognitive decline 527-33 pulmonary function threshold for distinguishing

ventilatory- and nonventilatory-limited patients 1245550

quality of life correlated with lung and muscle function 221-7

in elderly 1231-6 salbutamol early reversibility and bronchodilation pre-

diction after salmeterol in 1012-16 salmeterol vs ipratropium bromide effects on exercise

performance and breathlessness in 1116-21 vs oxitropium bromide as bronchodilators 354-7 (SR)

screening with pulse oximetry for long-term domiciliary oxygen need 1265-8

single breath vs re-breathing 7X0 18-24 subjective fatigue and physiological variables 676-82 survival in hospitalized population 568-72 tension-time index of inspiratory muscles 828835 time course of respiratory decompensation 93641 ventilation in ICU outcome 156661 vital prognosis following hospitalization 772-6

cognitive decline prediction in COPD 527-33 congestive heart failure effect on pulmonary function

1321-5 cortical blindness from bronchial artery embolization 983-6

(CR) corticosteroid

inhaler devices, asthma-related prescribing patterns with 1352-8

oral, effects on bronchodilator responses in COPD 279-82

pharmacology 385-94 treatment in COPD during oxygen therapy 50-56

cough, persistent, prescribing for 638-41 CPAP therapy failure in obstructive sleep apnoea syndrome

208-15 Cushing’s disease and TB 604-6 (CR)

INDEX

cyclosporin A effect on inflammatory cytokine production by alveolar macrophages 722-8

cystic fibrosis Buvklzolderia cepacia transmission and prevalence 178-83 diabetic retinopathy in 871-2 epithelial cell damage from neutrophil-derived proteases

in sputum 233340 hypomagnesaemic tetany from i.v. tobramycin in 6024

(CR) lobectomy in 695-7 (CR) nasal intermittent positive pressure ventilation 523-6 Nottingham Health Profile scores 268872 Xanthomonas maltophila respiratory infection therapy in

3634 (CR) cytokine

fragment 19 as diagnostic marker in bronchoalveolar lavage fluid in lung cancer 766-71

network in sarcoidosis 126-39 production by alveolar macrophages, cyclosporin A

effect 722-8 pro-inflammatory, compartmentalization in tuberculous

pleurisy 14-17 response, effect of hyperoxia 951-60

dermatomyositis and small cell lung cancer of lung 601-2 (CR) response to chemotherapy for non-small cell lung cancer

788-90(CR) diabetes, pulmonary aspergillosis and 972-5 (CR) diabetic retinopathy in cystic fibrosis 871-2 diaphragm shortening during hypercapnia in rats 48 Diskus vs Turbuhaler@ 105510 disodium cromoglycate vs ketotifen and beclomethasone

dipropionate effects on bronchial mucosa and asthma symptoms 942-50

DLCO impairment compared to BALF lymphocyte phenotype in systemic sclerosis 1295-301

dyspnea recovery time following exercise testing in COPD, effects of oxygen breathing and repeat testing 735-8

ECG changes in obstructive sleep apnoea syndrome 25-27

electric baseboard heating effect on lung function in primary school children 928-35

emphysema, lung volume reduction for, lung function and quality of life following increased elastic recoil after 653-8

empyema, salmonella, following splenic biopsy 968-9 (CR) endobronchial

non-Hodgkin’s lymphoma 975-7 (CR) secondaries occurrence 599-600 (SR)

eosinophil counts related to smoking and lung function 63-69

epithelial cell damage from neutrophil-derived proteases in cystic fibro-

sis sputum 23340 in sarcoidosis 126-39

EUROSOPC study on COPD 467-72 exercise

-induced asthma, gastro-oesophageal reflux and 1071-5 performance in COPD, salmeterol vs ipratropium bro-

mide effects on 1116-21 pulmonary rehabilitation programme effect on

1146654

submaximal, cardiorespiratory response in asthma following salbutamol and salmeterol 1053-X

test duration and dyspnea recovery time in COPD, effects of oxygen breathing and repeat testing 735-8

training and recovery in COPD after exacerbation 1191-8

Fas levels in COPD 993-9 fatigue, subjective, in COPD 676-82 Felty’s syndrome, pulmonary veno-occlusive disease com-

plicating 1089-91 (CR) FEV, value in COPD screening for PaO, ~7.3 kPa in

patients qualifying for long term 0, therapy 1122-6 fibrosis in sarcoidosis 140-9 finger clubbing in malignant mesothelioma and benign

asbestos pleural disease 691-2 (SR) fluticasone propionate

outcomes and cost-effectiveness audit 351-3 (SR) therapy in asthma 955104 delivery via inhaler and

Vdlumatic vs nebulized budesonide 111-17 forced spirometry, prediction equations in European popu-

lations 401-7 formoterol

efficacy in elderly with reversible obstructive airways disease 562-7

inhalation, onset and duration of action of single doses 1017-21

vs salbutamol onset of action in reversing methacholine- induced bronchoconstriction 1346651

vs salmeterol in reversible obstructive airways disease 83642

free radicals 609-23

gas compression profile during forced expiration in asthma and health 173-7

gastro-oesophageal reflux and exercise-induced asthma 1071-5 with haemoptysis and carinal erythematous lesion

1251-2 (CR) Gaucher disease, type 1: with pulmonary involvement,

alglucerase treatment 1370-2 (CR) gene mapping in families self-reporting asthma and allergy

1281-8 genetic polymorphism in asthma, ACE 1305-10 glucocorticoid

in asthma 385-94 receptor mRNA levels in bronchial epithelial cells in

COPD, effect of glucocorticoids 110229 granulocyte transit time through lung, bimodal, deconvol-

ution analysis 1163-6 (SC) growth in children with asthma, effects of beclomethasone

dipropionate comparison with budesonide (S.B.) 2245

haemopoietic progenitor cell transplantation, puhnonary Langerhans’ cell histiocytosis following autologous 1253-5 (CR)

haemoptysis with gastroesophageal reflux and carinal erythematous lesion 1251-2 (CR)

haemosiderosis, idiopathic pulmonary 902-7 health habits and illness behaviour 150-5 heart

disease and COPD 1256-7 (L) failure, congestive, nocturnal oxygen and hypercapnic

ventilatory response 426-3 1

IN~ZJEX

hepatocyte growth factor measurement in serum and bronchoalveolar lavage fluid in pulmonary fibrosis 273-8

histiocytosis, pulmonary Langerhans’ cell, following autologous haemopoietic progenitor cell transplantation 1253L5 (CR)

HLA-DQBl and HLA-DPBl genotypes in familial sarcoidosis 649-52

hospital stay following coronary artery bypass surgery, anaesthetic practice and 1066-70

house dust mite exposure evaluation 1099-101 swine, and levels of IL- l/3 and IL- 1 receptor antagonist in _ ,- peripheral blood 1022-7

hydrofluoroalkane-134a, delivery improvement of beclom- ethrisone dipropionate (S.A.) 3-39

hypercapnia in rats, diaphragm shortening and intrathoracic pressure during 4-8

hypercapnic respiratory failure, nasal intermittent positive pressure ventilation 523-6

hypercapnic vehtilatory response in congestive heart failure 426-3 1

hypersensitivity pneumonitis caused by cyclosporine 1368-70 (CR)

hypomagnesaemic tetany from iv. tobramycin in cystic fibrosis 602-4 (CR)

hypoxia effect on macrophage cytokine response 951-60 on renal hormonal balance in COPD 1331-6

ICU stay following coronary artery bypass surgery, anaes-

thetic practice and 1066-70 ventilation outcome in COPD 156-61

illness behaviour, health habits and 150-5 inflammatory bowel disease, lung function 516-22 influenza vaccination effect on airway responsiveness in

asthma 1010-l 1 inhaler

comparison 105-10, 11 l-17 new powder, salbutamol bronchoprotection 578-83

integrin expressions by mononuclear phagocytes in peripheral blood and BALF 1326-30

interleukin-lp and receptor antagonist levels in peripheral blood from swine house dust inhalation 1022-7

interleukin-8 expression in BAL cells to evaluate alveolitis in idio-

pathic pulmonary fibrosis 338-44 secretion by alveolar macrophages, smoking and 922-7

by bronchial epithelial cells, N-acetylcystein inhibition of IL-la-induced 512-15

interstitial lung piseases, ~53 protein overexpression 184-90 intrathoracic pressure during hypercapnia in rats 4-8 IPPV in cystic fibrosis and hypercapnic respiratory failure

523-6 ipratropium bromide vs salmeterol effects Zm exercise per-

formance and breathlessness in COPD 1116-21 isocyanate-induced asthma, bronchial hyperresponsiveness

without specific response to isocyanate in 1093-8 itraconazole therapy of allergic bronchopulmonary

aspergillosis 118-19

Jo-l syndrome, pulmonary fibrosis in polymyositis in 1167-9 (CR)

ketotifen vs disodium cromoglycate and beclomethasone dipropionate effects on bronchial mucosa and asthma symptoms 942-50

Kviem-Siltbach test 126-39

lactate dehydrogenase to distinguish transudates from exudates 762-5

Langerhans’ cell histiocytosis, pulmonary, following autologous haemopoietic progenitor cell transplantation 1253-5 (CR)

leukocyte counts in sputum in occupational asthma 550-7 leukotriene

antagonism in asthma and rhinitis,795-809 D,/E, receptor antagonist for diffuse panbronchiolitis

1084-6 (CR) Light’s criteria vs biochemical parameters to distinguish

transudates from exudates 762-5 lignocaine

inhalation effect on FEV, and bronchial reactivity in asthma 1359-63

levels during fibreoptic bronchoscopy in local anaesthesia 4043

liver disease, chronic, blood gases in non-smoking women 57-72

lobectomy in cystic fibrosis 695-7 (CR) lung

abscess with squamous epithelial lining 790-l (CR) cancer, cytokine fragment 19 as diagnostic marker in

bronchoalveolar lavage fluid 766-71 non small-cell, inflammatory response 76-83

with malignant effusion, intrapleural paclitaxel for 473-9 response of dermatomyositis to chemotherapy for 788-90 (CR)

small cell, dermatomyositis and 601-2 (CR) deconvolution analysis of bimodal granulocyte transit

time 1163-6 (SC) disease hospitalization in early childhood 1003-9

interstitial, ~53 protein overexpression 184-90 in systemic sclerosis 1295-301

obstructive, prevalence in Sweden 133745 see also chronic obstructive lung disease (COPD)

endometriosis, CT scans 876-7 (CR) function, eosinophil and monocyte counts related to

smoking and 63-69 impairment, obstructive sleep apnoea syndrome symp-

toms related to 283-8 improvement following increased elastic recoil after

lung volume reduction surgery in emphysema 653-8

in inflammatory bowel disease 516-22 lignocaine inhalation effect on FEV, and bronchial

reactivity in asthma 1359-63 measurements, prediction equations in European

populations 401-7 of primary school children, domestic factors and

928-35 quality of life in COPD correlation 221-7

volumes, plethysmographic, prediction equations 454-60 reduction surgery in emphysema, improved lung func-

tion and quality of life following increased elastic recoil after 653-8

lymphocyte phenotype in BALF compared to DLCO impairment in systemic sclerosis 1295-301

lymphoma, large cell intravascular, pulmonary presentation of1087-9 (CR)

lymphomatoid granulomatosis mimicking sarcoidosis 966-8 (CR)

macrolide antibiotics for diffuse panbronchiolitis 1084-6 (CR)

macrophage alveolar, cyclosporin A effect on inflammatory cytokine

production by 722-8 smoking and interleukin-8 secretion by 92227

budesonide and terbutaline effects on phagocytosis in 162-6

cytokine response, effect of hyperoxia 951-60 phenotype in sputum, smoking and 415-20 in sarcoidosis 126-39

malignant mesothelioma, finger clubbing 691-2 (SR) MDPI inhaler, salbutamol bronchoprotection 578-83 mechanical ventilation for acute severe asthma mediastinal nonseminomatous germ cell tumour 882-4

(CR) meningitis and CD4 lymphocytopenia with pulmonary

cryptococcoma in HIV-negative patient 120-2 (CR) methacholine

bronchial responsiveness in relation to cold air inhalation and exercise-induced bronchoconstriction in asthma 308-15

challenge in asthma diagnostics 32-39 chloride, stability in solution, effect of pH 588-92 -induced bronchoconstriction, salbutamol vs formoterol

onset of action in reversing 1346-51 response characteristics in asthma, allergic rhinitis and

healthy subjects 88-94 methotrexate, management of steroid-dependent asthma

1059965 Mini-Wright peak flow meter 505-l 1 monocyte counts related to smoking and lung function

63-69 monoethylglycinexylidide levels during fibreoptic bron-

choscopy in local anaesthesia 4043 mononuclear phagocytes integrin expressions in peripheral

blood and BALF 1326630 Morgan Transflow system 628-32 mucociliary clearance, antibiotics effects during OPCD

exacerbation 44227 muscle function, quality of life in COPD correlation 221-7 mycetoma, pulmonary, from Can&a albicans 1079-80

(CR) Mycobacterium simiae pulmonary infection, reactive amyl-

oidosis in 123-4 (CR) Mycobacterium vaccae safety and outcome measures 597-8

(SR)

nasal continuous positive airway pressure for obstructive sleep apnoea syndrome 820-7 treatment interruption in obstructive sleep apnoea 28-3 1

nasal inflammation effect on bronchial asthma 547-9 nasal intermittent positive pressure ventilation in cystic

fibrosis and hypercapnic respiratory failure 523-6 nebulizer

therapy at home 1000-2 in adult asthma 62447

neural network study of relationship between air pollution and asthma-related emergency visits 11999202

neutrophil -derived proteases in cystic fibrosis sputum, damage to

epithelial cells 233-40 infiltrating bronchial epithelium in COPD 863-70

nitric oxide exhaled, relationship to markers of asthma severity

908-13 production, nasal, in perennial allergic rhinitis, effect of

topical steroids 558-61 and respiratory system 701-15

Nocaudia astevoides drug resistance in pulmonary nocardiosis 873-5 (CR)

non-Hodgkin’s lymphoma, endobronchial975-7 (CR)

obstructive airways disease reversible, efficacy of formoterol in elderly 562-7

formoterol vs salmeterol in 836-42 see also chronic obstructive airways disease

obstructive sleep apnoea syndrome ambulatory diurnal sleep recording 216-20 appearance of central apnoea following auto-CPAP

891-3 (CR) CPAP therapy failure in 208-15 ECG changes 25-27 nasal continuous positive airway

pressure treatment interruption 28-3 1 hypopnoea number effect on therapy 1028-31 symptoms related to bronchitic symptoms or lung func-

tion impairment 283-8 osteosarcoma, chondroblastic, endobronchial metastases in

786-8 (CR) oxitropium bromide

effects on bronchodilator responses in COPD 279982 vs salmeterol as bronchodilators in COPD 354-7 (SR)

oxygen breathing effects, exercise test duration and dyspnea

recovery time in COPD 735-8 levels during dialysis in pressure support ventilation

53440 need, COPD screening with pulse oximetry for long-term

domiciliary 1265-8 saturation changes in fibreoptic bronchoscopy 739942 supply, concentrators in domiciliary situation 250-5 therapy in COPD, corticosteroid treatment during 50-56

and FEV, value in COPD screening for Pa0,<7.3 kPa 1122-6

long-term, characteristics and complaints of patients 70-75 liquid vs oxygen concentrators or compressed gas cylinders, patient characteristics 84-87

nocturnal, in congestive heart failure 426631 patient compliance improvement 1203-6

transcutaneous level changes in fibreoptic bronchoscopy 73942

p53 protein overexpression in interstitial lung diseases 184-90

paclitaxel, intrapleural, for non small-cell lung cancer with malignant effusions 473-9

panbronchiolitis: diffuse, treated with low-dose macrolide antibiotics and leukotriene D,/E, receptor antagonist 1084-6 (CR)

PaO, in asthma, bronchoalveolar lavage effects on 191-7 papilloma, bronchial solitary columnar 787-9 (CR) parasitic alveolitis parallels with asthma l-3

INDEX

patient behaviour and health habits 150-5 compliance, diary compared to monitor recording

1188-90 improvement with long-term oxygen therapy following

formal assessment and training 120336 PCR for diagnosis of smear-negative pulmonary TB 8 15-19 peak flow meters compared 505-l 1 PEF diurnal variability related to nitric oxide exhalation

908-13 peripheral airways obstruction on CT in chronic severe

asthma 448-53 phagocytosis in alveolar macrophages, budesonide and

terbutaline effects 162-6 plethysmographic lung volumes, prediction equations

454-60 pleural

biopsy vs pleuroscopy in malignant effusion or tuberculous pleurisy 488892

brushing, closed percutaneous 659-63 disease from asbestos, finger clubbing in 691-2 (SR) effusion, Light’s criteria vs biochemical parameters to

distinguish transudates from exudates 762-5 malignant, pleurodesis with small percutaneous cath-

eter 593-6 use of curved chest tube drainage 633-7

mass developing following talc pleurodesis 358-9 (CR) pleurisy, tuberculous, pro-inflammatory cytokine compart-

mentalization 14-17 pleuropulmonary disease as side-effect of treatment with

bromocriptine 11724 (CR) pneumonia

bacterial, rhabdomyolysis and 359-62 (CR) community-acquired, early transition to oral antibiotic

therapy 1032-9 time course of symptom resolution 113742

eosinophilic, bronchoalveolar lavage cells 743-9 Pseudomonas putida with mucoid phenotype 693-7 (CR)

pneumothorax drainage with iv. catheter 961-2 (CR) persistent air leak 767-61 in pulmonary tuberculosis 1269-73 recurrent spontaneous, in bronchial asthma 887-9 (CR) spontaneous, delayed referral reduction of success in

video-assisted thoracoscopy 246-9 impact on smoking behaviour in young people 1132-6

polymyositis and pulmonary fibrosis in Jo-1 syndrome 1167-9(CR)

positive end-expiratory pressure effect in cardiac surgery 858862

prednisolone in acute childhood asthma 541-6 protease

damage to epithelial cells in cystic fibrosis sputum 23340 -inhibitor system Z, alpha,-antitrypsin deficiency risk in

pulmonary emphysema 241-5 Pseudomonas-derived proteases in cystic fibrosis sputum,

damage to epithelial cells 23340 Pseudomonas putida with mucoid phenotype, pneumonia

from 69337 (CR) Pulmo-graph peak flow meter 505-l 1 pulmonary

adenomatoid malformation presenting as unilobar cysts in adult 1364-7 (CR)

aspergillosis in insulin-dependent diabetic 972-5 (CR)

cryptococcoma with CD4 lymphocytopenia and meningitis in HIV-negative patient 120-2 (CR)

disease, domiciliary non-invasive ventilation in elderly patients 13 1 l-20

edema following chronic upper airway obstruction 1174-6 (CR)

emphysema, alpha,-antitrypsin deficiency PiSZ, risk factor in 241-5

eosinophilia, tropical, pathogenesis l-3 fibrosis, hepatocyte growth factor measurement in serum

and BAL 273-8 idiopathic, interleukin-8 expression in BAL cells to

evaluate alveolitis in 33844 in polymyositis with the Jo-l syndrome 1167-9 (CR)

function in asthma 849-57 effect of long-standing heart failure 1321-5 laboratories re-audit 1155562 threshold for distinguishing ventilatory- and

nonventilatory-limited patients with airflow obstruction 1245-50

haemosiderosis, idiopathic 902-7 infarction revealing pulmonary Takayasu’s arteritis

969-71 (CR) infection, reactive amyloidosis in 12304 (CR) infiltrates, migratory 108 l-4 (CR) involvement with type 1 Gaucher disease, alglucerase

treatment 1370-2 (CR) Langerhans’ cell histiocytosis following autologous hae-

mopoietic progenitor cell transplantation 1253-5 (CR)

mycetoma from Candida a&cans 1079-80 (CR) nocardiosis, drug resistance in 873-5 (CR) ossification, diffuse, in bronchial asthma 887-9 (CR) presentation of intravascular large cell lymphoma 1087-9

(CR) rehabilitation programme effect on exercise performance

and quality of life 1146-54 tuberculosis in adults in Scotland 1289-94 vasculitis with anti-Jo-l antibodies 986-8 (CR) veno-occlusive disease complicating Felty’s syndrome

1089991 (CR) diagnosis 979-83 C(R)

pulse oximetry COPD screening for long-term domiciliary oxygen need

1265-8 at fibreoptic bronchoscopy in local anaesthesia 532-7 in smokers 989-90 (L)

quality of life analysis in sarcoidosis 750-6 in COPD correlated with lung and muscle function 221-7 in elderly with COPD 1231-6 improvement following increased elastic recoil after lung

volume reduction surgery in emphysema 653-8 measurement in asthma 1207-14 pulmonary rehabilitation programme effect on 1146-54

re-breathing vs single breath TLC0 in COPD 18-24 renal hormonal balance in COPD, hypoxia effect on 1331-6 respiratory

decompensation time course in COPD 936-41 failure, hypercapnic, secondary to sclerodermic chest wall

restriction, non-invasive ventilation in 1170-2 (CR) system compliance following thoracoplasty 810-14 symptoms prevalence in Sweden 1337-45

rhabdomyolysis and bacterial pneumonia 359-62 (CR) rhinitis

chronic non-asthmatic, hypo-osmolar aerosol induction of hyperventilation in 9-13

leukotriene antagonism in 7955809

salbutamol ‘as required’, vs salmeterol in asthmatic children 292-9 bronchoprotection from new powder inhaler 578-83 early reversibility and bronchodilation prediction after

salmeterol in C6PD 1012-16 effects on bronchodilator responses in COPD 279-82 in Turbuhalera for acute asthma 167-72 and salmeterol in asthma, cardiorespiratory response to

submaximal exercise following 1053-8 use recording on diary card compared to compliance

monitor recording 1188-90 via Turbuhaler@ vs metered-dose inhaler in asthma

325-30 vs formoterol onset of action in reversing methacholine-

induced bronchoconstriction 134651 salmeterol

and salbutamol in asthma, cardiorespiratory response to submaximal exercise following 1053-8

early reversibility and bronchodilation prediction in COPD after 1012-16

trials in asthma 777-82 vs ‘as required’ salbutamol in asthmatic children 292-9 vs formoterol in reversible obstructive airways disease

836-42 vs ipratropium bromide effects on exercise performance

and breathlessness in COPD 1116-21 vs oxitropium bromide as bronchodilators in COPD

354-7 (SR) vs slow-release theophylline for long-term therapy in

asthma 683390 vs theophylline in asthma 256663 xinafoate in asthma 1302-4 (SR)

salmonella empyema following splenic biopsy 96889 (CR) sarcoidosis

clinical manifestation, staging and therapy 140-9 historical perspective and immunopathogenesis 126-39

familial, HLA-DQB 1 and HLA-DPBl genotypes 649-52 quality of life analysis 750-6 recurrent venous obstruction 785-9 (CR)

sclerodermic chest wall restriction: non-invasive ventilation in hypercapnic respiratory failure secondary to 1170-2 (CR)

sclerosis, amyotrophic lateral, long-term mechanical ventilation 438841

serum markers for sarcoidosis 140-9 single breath

transfer factor measurement 628-32 vs re-breathing TLC0 in COPD 18-24

skin changes, effects of beclomethasone dipropionate comparison with budesonide (S.B.) 245

sleep apnoea see obstructive sleep apnoea sleep

-disordered breathing comparison in Asians and Caucasians 843-8

recording, diurnal ambulatory, in obstructive sleep apnoea syndrome 2 16-20

smoking behaviour, effect of pneumothorax in young people

1132-6

habits, social processes in development 150-5 eosinophil and monocyte counts related to lung function

and 63-69 and interleukin-8 secretion by alveolar macrophages

92227 macrophage phenotype in sputum 415-20 by mother, socioeconomic status and birth order effect

on childhood allergy 123744 passive, effect on lung function in primary school chil-

dren 928-35 pulse oximetry 989-90 (L)

snoring, Breathe Right@ effects on 1076-8 socioeconomic status and maternal smoking effect on child-

hood allergy 123744 spirometer, electronic hand-held 1177-80 spirometric

measurement selection 4988504 reference equations for older adults 914-21

splenic biopsy, salmonella empyema following 968-9 (CR) steroid ‘, I’

-dependent asthma, management with methotrexate 1059-65

inhaled, improved delivery with hydrofluoroalkane-134a (S.A.) 3-8

topical, effect on nasal nitric oxide production in perennial allergic rhinitis 558-61

see also corticosteroid swine house dust and levels of IL-lp and IL-l receptor

antagonist in peripheral blood 102227 systemic sclerosis, interstitial lung disease in 1295-301

T cell lymphocytopenia, CD4’, miliary TB causing acute

respiratory failure in 977-9 (CR) receptor subsets of lymphocytes in bronchoalveolar

lavage in pulmonary TB 408-14 in sarcoidosis 1266239

Takayasu’s arteritis, pulmonary infarction revealing 969-71 (CR)

talc pleurodesis, apical pleural mass development following 35889 (CR)

terbutaline effects on phagocytosis in alveolar macrophages 162-6 q.i.d. compared to formoterol b.i.d. via Turbuhaler@

1040-5 theophylline

vs salmeterol in asthma 256663 vs slow-release salmeterol for long-term therapy in

asthma 683-90 thoracic gas compression profile during forced expiration in

asthma and health 173-7 thoracoplasty, total respiratory system compliance 810-14 thoracoscopy

results and complications 228-32 video-assisted, delayed referral reduction of success in

spontaneous pneumothorax 246-9 thymic carcinoid with mutinous stroma 880-2 (CR) tobramycin, i.v., hypomagnesaemic ‘tetany in cystic fibrosis

6024 (CR) tracheal obstruction and pleomorphic adenoma 889-91

(CR) transfer factor for CO, single breath vs re-breathing, in

COPD 18-24 tuberculosis

case-finding in Australia, chest radiography and 198-202

INDEX

in cattle, human implications 990-l (L) contact tracing in low-incident area 1127-31 Cushing’s disease and 6046 (CR) miliary, causing acute respiratory failure in idiopathic

CD4’ T-lymphocytopenia 977-9 (CR) pleurisy, pleural biopsy vs pleuroscopy 488-92

pro-inflammatory cytokine compartmentalization 14-17

pulmonary, in adults in Scotland 1289-94 pneumothorax in 1269973 radiographic spectrum 493-7 T cell receptor subsets of lymphocytes in bronchoal-

veolar lavage in single pleural nodule in minor fissure 783*91 (CR) smear-negative pulmonary, rapid diagnosis via fibreoptic

bronchoscopy 8 15-19 Turbuhaler@

for beta,-agonists in acute asthma 167-72 low-dose formoterol b.i.d. compared to terbutaline q.i.d.

via 1840-5 vs Diskus 105-10 vs metered-dose inhaler in asthma, salbutamol in 325-30

ventilation domiciliary non-invasive, in elderly patients 131 l-20 during dialysis in pressure support ventilation 534-40 in ICU, outcome in COPD 156-61 long-term mechanical, in amyotrophic lateral sclerosis

438-41 nocturnal non-invasive, COPD outcome following

1215-22 non-invasive, in hypercapnic respiratory failure second-

ary to sclerodermic chest wall restriction 1170-2 (CR) .i

Vitalograph@ 2110 evaluation 1177780 von Willebrand factor .antigen plasma levels in acute bron-

chitis and, normal population 395400

Wright Pocket meter 505-l 1

Xanthomonas maltophila respiratory infection therapy in cystic fibrosis 3634 (CR)

INDEX

Author Index

Aaron SD, Dales RE, Pham B. Management of steroid- dependent asthma with methotrexate: a meta-analysis of randomized clinical trials 1059965

Abad J see Fiz JAF Abal-Arca J see Blanco-Perez J Abbey DE see McDonnell WF Abe M, Hashimoto S, Hara H. A case of diffuse panbron-

chiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D,/E, receptor antagonist 10846

Abe S see Tanaka H Abel AT, Parwer S, Sanyai SC. Pulmonary mycetoma

probably due to Candida albicans with complete resolution 1079-80 (CR)

Abisheganaden J see Chee CBE Adalioglu G see Saraclar Y Adams JP, Conway SP, Wilson C. Hypomagnesaemic

tetany associated with repeated courses of intravenous tobramycin in a patient with cystic fibrosis 602-4 (CR)

Adelroth E see Montnemery P Agnew JE see Hasani A Agusti AGN see Carrera M Agusti P see Xaubet A Aharon A, Langevitz P, Maran R, Blank-Porat D, Shtras-

burg S: Livneh A. Reactive amyloidosis in a patient with Mycobacterium simiae pulmonary infection 123-4

Aiolfi S see Confalonieri M Akagawa S see Shishido H Al-Ali M, Howarth PH. Nitric oxide and the respiratory

system in health and disease 701-15 Eames C, Howart H. Exhaled nitric oxide: relationship to

clinicophysiological markers of asthma severity 908-13

Al-Rawas OA see Carter R Alani FSS see Ormerdo LP Alanko K see Seppalb O-P Alcock SM, Mamun M, Prescott RJ, Connolly CK. Symp-

toms and pulmonary function in asthma 849-57 see also Connolly CK

Allen DB. Effect of inhaled beclomethasone dipropionate and budesonide on growth in children with asthma 37-45 (S.B.)

Alonso J see Monso E Alvarez A see Orriols R Alvarez D see ValdCs L Alvarez-Sala R see Valdes L Ambrodino N see Clini E Andersson B see Palmqvist M Andreadis D see Patakas D Andreas S, Miihlen F von zur, Stevens J, Kreuzer H.

Nocturnal oxygen and hypercapnic ventilatory response in patients with congestive heart failure 426-3 1

Andreoli A see Sergi M Angelo HR see Milman N Angus R see Thomson NC Ansari S, Thomas S, Campbell IA, Furness L, Evans MR.

Refined tuberculosis contact tracing in a low incidence area 1127-31

Anthi A see Michaelopoulos A

Antonelli Incaizi R, Chiappini F, Fuso L, Torrice IMP, Gemma A, Pistelli R. Predicting cognitive decline in patients with hypoxaemic COPD 527-33

Antoo JM see Rota J Anttinez J see Valdes L Antzaka C see Michalopoulos A Appleby JL see Price DB Arakawa M see Fujimori K Arends J-W see Korn SH Argyropoylou P see Patakas D Armstrong J segBrown I Asano K see Yasuda N Askgaard DS see Wilcke JTR Aslbach GPJ see Kampelmacher MJ Atherton ST see Kearney SE Atkin A see Dickinson J Atlas SJ see Metlay JP Au LY see Wong CF Aubert G see Liistro G Ayres JG see Boldy DAR Ayuso MC see Xaubet A Aznar J see Cremades MJ Azzolin NM see Baraldi E

Babera JA see Soler N Bacci E see Di Franc0 A Balder B, Lindholm NB, Lliwhagen 0, Palmqvist M,

Plaschke P, Tunsater A, TorCn K. Predictors of self- assessed work ability among subjects with recent onset ashtma 729-34

Ballardini L see Spanevello A Bamberga M see Sergi M Banham S see O’Reilly JF Bansai SK see Parameswaran K Bansal AS see Brown I Baraff LJ see Mower WR Baraldi E, Azzolin NM, Carra S, Dario C, Marchesini L:

Zacchello F. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: a pilot study 558-61

Barbara JA see Castellsague J Barb& F see Carrera M Barbera JA see Rota J; Xaubet A Barker KF see Janes SM Barley EA, Quirk FH, Jones PW. Asthma health status

measurement in clinical practice: validity of a new short and simple instrument 1207714

Barnes NC, Hallett C, Harris TAJ. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less 95-104

Barratt A see Skwarski K Barros-Tizon JC see Miravitlles M Bartoli ML see Di Franc0 A Basran GS see O’Reilly JF Bathe M see Soler N Becklake MR see Demissie K Bedi R see Gilthorpe MS Bein G see Schiirmann M Bell D see Janes SM Bellamy D see Partridge MR

Bellone A see Confalonieri M Benstrup KE, Jensen JI, Reintoft I. Lung abscess with

squamous epithelial lining 790-l (CR) Berg A von, de Blic J, la Rosa M, Kaad P-H, Moorat A.

A comparison of regular salmeterol vs ‘as required’ salbutamol therapy in asthmatic children 292-9

Bertacco S see Pesci A Biernacki W, Peake MD. Acupuncture in treatment of

stable asthma 1143-5 Bisgaard H, Nikander K, Munch E. Comparative study of

budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics 4449

Bjijrnsson E see Norrman E Blanco-Perez J, Borden J, Pifieiro-Amigo L, Rota-Serrano

R, Izquierdo R, Abal-Arca J. Pneumothorax in active pulmonary tuberculosis: resurgence of an old complication? 1269-73

Blank-Porat D see Aharon A Boe J see Nana A; Schaaning J Boldy DAR, Short PE, Cowen P, Hill FGH, Chambers

DC, Ayres JG. Plasma levels of von Willebrand factor antigen in acute bronchitis and in a normal population 395400

Boman G see Norrman E Bondesson E, Friberg K, Soliman S, Liifdahl C-G. Safety

and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered- dose inhaler in patients with asthma 325-30

Boobis AR. Comparative physicochemical and pharma- cokinetic profiles of inhaled beclomethasone dipropionate and budesonide (S.B.) 2-6

Borciani N see Pesci A Borden J see Blanco-Perez J Borowsky LH see Metlay JP Boudewyns A, Van de Heyning P, De Backer W. Appear-

ance of central apnoea in a patient treated by auto- CPAP for obstructive sleep apnoea 891-3 (CR)

Bourke SJ see Reid DW Bouros D, Tzanakis N, Psathakis K, Patsourakis G,

Rokkas T. Gastroesophageal reflux presented with haemoptysis and carinal erythematous lesion resembling in situ carcinoma 1251-2 (CR)

see also Tzanakis N Bousquet J see Demoly P Boyd G see O’Reilly JF Bragonier R, Grier D, Carswell F, Cunningham S. Lobec-

tomy in cystic fibrosis 695-7 (CR) Brambilla C see Devouassoux G Brambilla R see Thomson NC Bredin CP see Henry M Breslin EH see Breukink SO Bresnihan B see Kiely JL Breteler MHM see Wirnsberger RM Breukink SO, Strijbos JH, Koorn M, Koeter GH, Breslin

EH, Schans CP van der. Relationship between subjective fatigue and physiological variables in patients with chronic obstructive pulmonary disease 676682

Britton JR see Lewis SA Bromly CL see Reid DW Brooks G see Davies B Brown I, Joyce C, Hogan PG, Armstrong J, Steele R,

Bansal AS. Pulmonary vasculitis associated with anti- Jo-l antibodies 986-S (CR)

Burchette RJ see McDonnell WF Burgos F see Castellsague J; Rota J

Burnett I see Hamid S Burris J see Pierce JD Busby HK see Murata GH Bustamante A see Miravitlles M Buurman WA see Staal-van den Brekel AJ Byrd RP, Roy TM. Rhabdomyolysis and bacterial pneu-

monia 359-62

Cacciani G see Pesci A Calderaro F see Cazzola M Califano C see Cazzola M Callaway MP see Simpson JCG Campbell AP see Doherty MJ h Campbell IA see Ansari S Capdevila X see Hayot M Capurro M see Rodriguez MC Cargill K see Price DB Carlsen K-H, Engh G, Mark M, Schroder E. Cold air

inahalation and exercise-induced bronchoconstriction in relationship to methacholine bronchial responsiveness: different patients in asthmatic children and children with other chronic lung diseases 308-15

Carnevali S see Di Franc0 A Carr DH, Hibon S, Rubens M, Chung KF. Peripheral

airways obstruction on high-resolution computed tomography in chronic severe asthma 448-53

Carra S see Baraldi E Carrera M, Barbe F, Agusti AGN. Does the number of

hypopnoeas influence therapy in patients with obstructive sleep apnoea? 1028-31

Carrion M see Xaubet A Carswell F see Bragonier R Carter R, Al-Rawas OA, Stevenson RD, Naik SK,

Wheatley DJ. The measurement of the single-breath transfer factor for carbon monoxide and its components using the Morgan Transflow system ~628-32

Casan P see Gomez J; Rota J Casas F see Miravitlles M Castellsague J, Burgos F, Sunyer J, Barbara JA, Rota J.

Prediction equations for forced spirometry from European origin populations 401-7

see also Rota J Castronovo C see Sergi M Cave C see Dawson S Cayton RM see Hill AT Cazals V see Desmarquest P Cazzola M, Matera MG. Interrelationship between

pharmacokinetics and pharmacodynamics in choosing the appropirate antibiotic and the dosage regimen for treating acute exacerbation of chronic bronchitis 895- 901

Matera MG, Di Perna F, Calderaro F, Califano C, Vinciguerra A. A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease 354-7

Vinciquerra A, Di Perna F, Matera MG. Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive disease 1012-16

Cederlund K see Norman M Cetinkaya F see Saraclar Y Chadelat K see Desmarquest P Chadha D s,ee Parameswaran K Chambers DC see Boldy DAR Chan CHS see Hoheisel G

INDEX

Corroyer S see Desmarquest P Costabel U see Striz I Coulomb M see Devouassoux G Cowan ME see Doherty MJ Cowen P see Boldy DAR Cremades MJ, Memendez R: Pastor A: Llopis R, Aznar J.

Diagnostic value of cytokeratin fragment 19 (CYFRA- 21-1) in bronchoalveolar lavage fluid in lung cancer 766-7 1

Crompton GK see Simpson AJ Cunniffe J see Dev D Cunningham D see Kon OM Cunningham S see Bragonier R Cuomo A see Pesci A

Clan CY see Wong CF Chang BC see Ho CL Charles TJ, Hariraj R. Salmonella empyema following

splenic biopsy 968-9 (CR) Chatrou M see Smit HJM Chee CBE, Abisheganaden J; Yeo JKS, Lee P, Huan PYM,

Poh SC, Wang YT. Persistent air-leak in spontaneous pneumothorax - clinical course and outcome 757-61

Chen Y-M see Perng R-P Cheng AFB see Wong CF Chew FT, Goh DYT, Ooi BC, Lee BW. Time trends and

seasonal variation in acute childhood asthma in tropical Singapore 345-50 (SR)

Chiappini F see Antonelli Incaizi R Chisholm SL, Dekker FW, Knuistingh Neven A, Petri H.

Once-daily budesonide in mild asthma 421-5 Chou K-C see Perng R-P Chung KF see Carr DH; Demoly P Ciaccia A see Cogo AL Cianchetti S see Di Franc0 A Cicotti E see Janssens J-P Clancy RL see Pierce JD Clarke SW see Hasani A Clausen JL see Rota J Clement A see Desmarquest P Clementsen P, Evald T, Grode G, Hansen M, Krag

Jacobsen G, Faurschou P. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study 593-6

see also Hansen M Clerk AA see Ong KC Clini E, Sturani C, Porta R, Scarduelli C, Galavotti V,

Vitacca M, Ambrodino N. Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation 1215-22

Cochrane GM see Hamid S Cogo AL, Ferrari M, Fugagnoli A, Micheletto C; Ciaccia

A. Hypo-osmolar aerosol induces hyperventilation in chronic non-asthmatic rhinitis 9-13

Co11 R see Monsb E Cola L see Kalyoncu AF Comet R, Domingo C, Such JJ, Ribera G, Sans J, Mar-in A.

Pleuropulmonary disease as side-effect of treatment with bromocriptine 1172-4 (CR)

Confalonieri M, Gazzaniga P, Gandola L, Aiolfi S, Della Porta R, Frisinghelli A: Bellone A. Haemodynamic response during initiation of non-invasive positive pressure ventilation in COPD patients with acute ventilatory failure 33 1-7

Congleton J: Hodson ME, Duncan-Skingle F. Do Notting- ham Health Profile scored change over time in cystic fibrosis? 268-72

Connolly CK, Mamun M; Alcock SM, Prescott RJ. The Darlington and Northallerton Prospective Asthma Study: best function predicts mortality during the first 10 years 1274-80

see also Alcock SM Connolly MJ see Yohannes AM Conway SP see Adams JP Cooper CB see Marques-Magallanes JA Corden Z, Rees PJ. The effect of oral corticosteroids on

bronchodilator responses in COPD 279-82 Corden ZM see Hamid S Cormier RA see Watson BL

D’Souza M. Comparative review of the effects of inhaled beclomethasone dipropionate and budesonide on bone (S.B.) 24436

Daganou M see Dimopoulou I Dahl R. Foreword (S.B.) 1

see also Jensen EJ; Mygind N Dahlen B, Melillo G. Inhalation challenge in ASA-induced

asthma 378-84 Dales RE see Aaron SD Darby H see Price DB Dario C see Baraldi E Davidson RN see Marshall BG Davies B, Brooks G, Devoy M. The efficacy and safety

of salmeterol compared to theophylline: meta-analysis of nine controlled studies 256663

Davies MG see Fitch PS Davies RJ, Stampone P, O’Connor BJ. Hydrofluoroalkane-

134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose (S.A.) 23-32

see also Thompson PJ Dawson S, Cave C, Pavord I, Potter JF. Transcutaneous

monitoring of blood gases: is it comparable with arterialized earlobe sampling? 584-7

De Backer W see Boudewyns A de Blic J see Berg A von de Boisblanc BP see Omidvari K de Vries J see Wirnsberger RM Deguchi K see Shishido H Dekhuijzen PNR see Schayk CP van Dekker FW see Chisholm SL Deliyanni M see Michalopoulos A Della Cioppa G see Vervloet D Della Porta R see Confalonieri M Demedts MG see Nollet AS Demissie K, Ernst P, Joseph L, Becklake MR. The role of

domestic factors and day-care attendance on lung function of primary school children 928-35

Demoly P, Chung KF. Pharmacology of corticosteroids 385-94

Jaffuel D, Sahla H, Bousquet J, Michel F-B, Godard P. The use of home nebulizers in adult asthma 624-7

Dente FL see Di Franc0 A Dentener MA see Staal-van den Brekel AJ Derom E see Ringdal M

INDEX

Desmarquest P, Chadelat K, Corroyer S, Cazals V, Clem- ent A. Effect of hyperoxia on human macrophage cytokine response 95 I-60

Dev D, Wallace E, Sanakaran R, Cunniffe J, Govan JRW, Wathen CG, Emmanuel FXS. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease 664-7

Devereux G, Evans MJ, Kerr KM, Legge JS. Pulmonary veno-occlusive disease complicating Felty’s syndrome 1089-91

Devouassoux G, Pison C, Witmeyer P, Tony F, Coulomb M, Brambilla C. Pulmonary infarction revealing pulmonary Takayasu’s arteritis 969-71 (CR)

Devoy M see Davies B Di Benedetto G see Vervloet D Di Franc0 A, Vagaggini B, Bacci E, Bartoli ML, Cianchetti

S, Carnevali S, Dente FL, Giannini D, Macchioni P, Ruocco L, Paggiaro PL. Leukocyte counts in hypertonic saline-induced sputum in subjects with occupational asthma 550-7

Di Perna F see Cazzola M Dickinson J, Hutton S, Atkin A. Implementing the British

Thoracic Society’s guidelines: the effect of a nurse-run asthma clinic on prescribed treatment in an English general practice 264-7

Dimopoulou I, Daganou M, Tsinstzas OK, Tzelepis GE. Effects of severity of long-standing congestive heart failure on pulmonary function 1321-5

Dluhy RG. Effect of inhaled beclomethasone dipropionate and budesonide on adrenal function, skin changes and cataract formation (S.B.) 15-23

Doboszynska A see Domagala-Kulawik J Doherty MJ, Campbell AP, Cowan ME, Greenstone MA.

Bilateral endobronchial metastases due to a chondroblastic osteosarcoma 786-8 (CR)

Kishore Kumar S, Nicholson AA, McGivern DV. Car- diac sarcoidosis: the value of MRI in diagnosis and assessment of response to treatment 69779 (CR)

Domagala-Kulawik J, Hoser G, Doboszynska A, Kawiak J, Droszcz W. Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLCO impairment 12955301

Domingo C see Comet R Donnell D see Thompson PJ Donohoe P see Kiely JL Dossing M see Wilcke JTR Douglas JG see McLean AN Douglas NJ see Mackay TW Douze JM see Kampelmacher MJ Dowson LJ, Mushtaq M, Watts T, Shurvinton J, Gooch R,

Hayton R, Jones JM, Perks WH. A re-audit of pulmonary function laboratories in the West Midlands 1155-62

Doyon F see Maury E Drent M see Staal-van den Brekel AJ; Wirnsberger RM Droszcz W see Domagala-Kulawik J du Bois RM see Nageh, TT Dubinett SM see Meissner H-H Duce Gracia F see Vervloet D Duncan-Skingle F see Congleton J Dury M see Liistro G

Eames C see Al-Ali MK Ebden P see Evans EN Edenborough FP see Hill AT

Edwards J see Roberts CM Eide GE see Svanes C Eklund A see Lensmar C Ekstriim T, Ringdal N, Sobradillo V, Runnerstrom E,

Soliman S. Low-dose formoterol Turbuhaler@ (Oxis@) b.i.d., a 3-month placebo-controlled comparison with terbutaline (q.i.d.) 1040-5

see also Vervloet D Elmberger G see Lensmar C Emad A, Rezaian Gr. Closed percutaneous pleural brush-

ing: a new method for diagnosis of malignant pleural effusions 659-63

Rezaian GR. Diagnostic value of closed percutaneous pleural biopsy vs pleuroscopy in suspected malignant pleural effusion or tuberculous plerisy in a region with a high incidence of tuberculosis: a comparative age-dependent study 488-92

Rezaian GR. Single pleural nodule in the minor fissure: an unusual manifestation of tuberculosis 7834 (CR)

Emmanuel FXS see Dev D Empey DW see Taylor RFH Engh G see Carlsen K-H Enright PL see McDonnell WF Ernst P see Demissie K Escarrabill J, Estops R, Farrero E, Monasterio C, Manresa

F. .Long-term mechanical ventilation in amyotrophic lateral sclerosis 43841

Escudero C see Miravitlles M Espaiia PP see Miravitlles M Estops R see Escarrabill J Evald T see Clementsen P Evans EN, Ganeshalingham K, Ebden P. Changes in

oxygen saturation and transcutaneous carbon dioxide and oxygen levels in patients undergoing fibreoptic bronchoscopy 73942

Evans MJ see Devereux G Evans MR see Ansari S Ewig S see Schafer H

Farrero E see Escarrabill J Faurschou P see Clementsen P; Hansen M Ferini-Strambi L see Sergi M Ferrari M see Cogo AL Ferrer0 0 see Martinez Odriozola P Filley E see Kon OM Fink G, Lebzelter J, Turner D, Klainman ‘E, Shlomo M,

Katz I, Kramer M, Spitzer S. Pulmonary function threshold for distinguishing ventilatory- and nonventilatory-limited patients with airflow obstruction 1245-50

Fireman Z see Weiner P Fitch PS, Smith MEF, Davies MG, Prentice AG. A case of

lymphatoid granulomatosis mimicking sarcoidosis 966-8 (CR)

Fitting J-W see Janssens J-P Fiz JAF, Abad J, Riera M, Izquierdo J, Morera J. CPAP

treatment interruption in OSA patients 28831 Fiz JM see Monso E Fluge 0 see Svanes C Fokkens JK see Jansons H Franklin DH see McLean AN Franklin J see Roberts CM Friberg K see Bondesson E Frisinghelli A see Confalonieri M Frossard N see Kopferschmitt-Kluber MC

Frost GD, Penrose A, Hall J, MacKenzie DIC. Asthma- related prescribing patterns with four different corticosteroid inhaler devices 1352-8

Fugagnoli A see Cogo AL Fujimori K, Arakawa M. Clinical factors that affect blood

gases in non-smoking women with chronic liver disease 57-62

Fujimura M, Yasui M, Shinagawa S, Nomura M, Matsuda T. Bronchoalveolar lavage cell findings in three types of eosinophilic pneumonia: acute, chronic and drug- induced eosinophilic pneumonia 74339

Fujita J, Negayama K, Ohara M, Hojo S, Obayashi Y, Miyawaki H, Yamaji Y: Takahara J. Pneumonia caused by Pseudomonas putida with a mucoid phenotype 693-5 (CR)

see also Hojo S; Yamanouchi H Fujiwara H see Yasuda N Fuller R see Verberne AAPH Furness L see Ansari S Fuso L see Antonelli Incaizi R

Gabrielli M see Pesci A Galavotti V see Clini E Gandola L see Confalonieri M Ganeshalingham K see Evans EN Garcia Pais MJ see Perez de Llano LA Garcia Salgado MJ see Losa Garcia JE Gautier-Dechaud V see Hayot M Gaya H see Taylor RFH Gazquez I, Parcel JM; Vives M, Vicente de Vera MC,

Rubio M, Rivas MC. Comparative analysis of Light’s criteria and other biochemical parameters for distinguishing transudates from exudates 762-5

Gazzaniga P see Confalonieri M Gemma A see Antonelli Incaizi R Geroulanos S see Michaelopoulos A Giannini D see Di Franc0 A Gillissen A, Nowak D. Characterization of N-acetylcysteine

and ambroxol in anti-oxidant therapy 609923 Gilthorpe MS, Lay-Yee R; Wilson RC, Walters S, Griffiths

RK, Bedi R. Variations in hospitalization rates for asthma among Black and ethnic minority communities 642-8

Glass DM see Ussov WY Gleissberg G see Kon OM Glerant JC see Hellmuth D Godard P see Demoly P Goh DYT see Chew FT Gomez F see Rodriguez MC Gomez J, Mota S; Casan P, Sanchis J. Pulse oximetry in

smokers 989 (L) Gon Y see Matsumoto K Gonzalez-Juanatey JR see ValdCs L Gooch R see Dowson LJ Goodchild MC see Millar-Jones L : Gooszen HC see Roelofs PM Gorgels WJMJ see Schayk CP van . . Gostelow B see Williams T Gotoh K see Yasuda N Govan JRW see Dev D Goyai M see Kon OM Graham DR see Kearney SE Greco M see Sergi M Greenstone MA see Doherty MJ Grier D see Bragonier R

Griffiths RK see Gilthorpe MS Grode G see Clementsen P Grossman AB see Thompson PJ .“’ ’ Grunsven PM van see Schayk CP van Guidet B see Maury E Guido P see Resta 0 Gulsvik A see Svanes C Gutierrez V see Prieto L Guzman J see Striz I Gyi KM see Yung B

Hader S see Matthys D Hall IP see Johnson PH Hall J see Frost GD Hallas TE. Pitfalls in evaluating mite exposure from house-

dust samples 1099-101 Hallett C see Barnes NC Hamid S, Corden ZM, Ryan DP, Burnett I, Cochrane GM.

Evaluation of an electronic hand-held spirometer in patients with asthma 1177-80

Kumaradevan J, Cochrane GM. Single centre open study to compare patient recording of PRN salbutamol use on a daily diary card with actual use as recorded by the MD1 compliance monitor 1188-90

Hancox M. Cattle TB crisis? Human implications 990-l (L) Hanley ML see Roberts CM Hansen M, Faurschou P, Clementsen P. Medical thoracos-

copy, results and complications in 146 patients: a retrospective study 228-32

see also Clementsen P Haponik E see Omidvari K Hara H see Abe M Harbeck RJ see Watson BL Hardy CC see Simpson JCG Harirraj R see Charles TJ Harris TAJ see Barnes NC Harrison BDW see Partridge MR Harrison LI see Seale JP .

Harrison TW, Tattersfield AE. Effec”t of single doses of inhaled lignocaine on FEV, and bronchial reactivity in asthma 1359963

Hasani A, Pavia D, Rotondetto S, Clarke SW, Spiteri MA, Agnew JE. Effect .of oral antibiotics on lung mucociliary clearance during exacerbation of chronic obstructive pulmonary disease 442-7

Hasegawa S see Ishikawa H; Morishima Y 1’) Hashimoto S see Abe M; Matsumoto K ,i Hasper E see Schafer H Hayot M, Perrigault PF, Gamier-Dechaud V: Capdevila X:

Milic-Emili J, Prefaut Ch, Ramonatxo M. Tension- time index of inspiratory muscles in COPD patients: role of airway obstruction 828-35

Hayton R see Dowson LJ .)‘JC Y” L Heald SH see Simpson AJ Heck CL van see Wirnsberger RM ‘-; Hedman J; Poussa T, Nieminen MM. A rapid dosimetrii:

methacholine challenge in asthma diagnostics: a clinical study of 230 patients with dyspnoea, wheezing or a cough of unknown cause 32,39

see also Seppala O-P ,-, Hellmuth D, Glerant JC, Sevestre H, Remond A,

Jounieaux V. Pulmonary adenomatoid malformation presenting as unilobar cysts in adult 13647 (CR) 1.

Hendrick DJ see Reid DW ii. I.,

Henry M, Landers R, Kealy WF, Bredin, CP. Solitary columnar bronchial :papilloma: a rare endoscopic finding 878-9 (CR) \I

Herrala J see Sepplla O-P Herwaarden CLA van see Palen J van der; Schayk CP van Heuman K see Montnemery P Hibon S see Carr DH Hildreth AJ see Parameswaran K Hill AT, Edenborough FP, Cayton RM, Stableforth DE.

Long-term nasal intermittent positive pressure ventilation in patients with cystic fibrosis and hypercapnic respiratory failure (1991-1996) 523-6

Hopkinson RB, Stableforth DE. Ventilation in a Birmingham intensive care unit 1993-1995: outcome for patients with chronic obstructive pulmonary disease 156-61

Stewart PM, Hughes EA, McLeod DT. Cushing’s disease and tuberculosis 604-6 (CR)

Hill FGH see Boldy DAR Hill LS, Slater AL. A comparison of the performance of

two modern multidose dry powder asthma inhalers 10.5-10

Hillerdal G see Norman M Hines E see Nutman A Ho CL, Chang BC, Hsu GC, Wu CP. Pulmonary crypto-

coccoma with CD4 lymphocytopenia and meningitis in an HIV-negative patient 120-2

Hobbs J see Langton Hewer S Hodson ME see Congleton J; Yung B Hogan PG see Brown I Hoheisel G, Izbicki G, Roth M, Chan CHS, Leung JCK,

Reichenberger F, Schauer J, Perruchoud AP. Com- partmentalization of pro-inflammatory cytokines in tuberculous pleurisy 14-17

Hojo S, Fujita J, Yamadori I, Kamei T, Yoshinouchi T, Ohtusuki Y, Yamaji Y, Takahara J. Overexpression of p53 protein in interstitial lung diseases 184-90

see also Fujita J; Yamanouchi H Hopkinson RB see Hill AT Horie T see Matsumoto K Horsfield N see Ormerdo LP Hoser G see Domagala-Kulawik J Hoshino GH, Nakamura Y, Sim JJ, Tomioko H. A com-

parative study of the effects of ketotifen, disodium cromoglycate and beclomethasone diprioponate on bronchial nucosa and asthma symptoms in patients with atopic asthma 942250

Howart H see Al-Ali MK Ijsu GC see Ho CL Huan PYM see Chee CBE Huang C-C, Lin M-C, Yang C-T, Lan R-S, Tsai Y-H, Tsao

TCY. Oxygen, arterial blood gases and ventilation are unchanged during dialysis in patients receiving pressure support ventilation 534-40

Hubbard M see Picciotto A Hughes EA see Hill AT

i”

Hughes JMB see Ussov WY Hughes P see McGavin C Hulks G see Mackay TW Hutchison DCS. (1-antitrypsin deficiency in Europe:

geographical distribution of Pi type S and Z 367- 77

Hutton S see Dickinson J Hyland ME see Singh SJ

Ide J see Roberts CM Ikeda A see Koyama H Ikeda H see Suzuki Y Ikeda Y, Yamashita H, Tamura T. Diffuse pulmonary

ossification and recurrent spontaneous pneumothorax in a patient with bronchial asthma 887-9 (CR)

Ind PW see Spanevello A Inuzuka M see Tanaka H Ip M see Tsang KWT Ishikawa H, Satoh H, Yamashita YT, Kamma H, Naito T,

Ohtsuka M, Hasegawa S. Curved chest tube for drainage of malignant pleural effusion 633-7

Izbicki G see Hoheisel G Izquierdo J see Fiz JAF; Monso E Izquierdo R see Blanco-Perez J Izumi T see Koyama H

Jackson M, Shneerson J. An evaluation of the use of concentrators for domiciliary oxygen supply for less than 8 h day- ’ 250-5

Jaffuel D see Demoly P Janes SM, Barker KF, Mak V, Bell D. Invasive pulmonary

aspergillosis in an insulin-dependent diabetic 972-5 (CR)

Jansons H, Fokkens JK, Tweel I van der, Kreukniet J. Re-breathing vs single breath 7X!O in patients with unequal ventilation and diffusion 18-24

Janssens J-P, Cicotti E, Fitting J-W, Rochat T. Non- invasive home ventilation in patients over 75 years of age: tolerance, compliance, and impact on quality of life 13 1 l-20

Jansson C see Norrman E Jardi R see Miravitlles M Jarnvig I-L see Kristensen MS Jauregui I see Martinez Odriozola P Jeffery GM see McRae WM Jensen EJ, Pedersen B, Narvestadt E, Dahl R. Blood

eosinophil and monocyte counts are related to smoking and lung function 63-69

Jensen G see Vestbo J Jensen JI see Benstrup KE Jeong SW see Uh S-T Jimenez Lopez A see Losa Garcia JE Johannisson A see Montnemery P Johansson S-A see Montnemery P Johnson PH, Wilkinson I, Sutherland AM, Johnston ISA,

Hall IP. Improving communication between hospital and primary care increases follow-up rates for asthmatic patients following casualty attendance 289991

Johnston ISA see Johnson PH Jolobe OMP. Survival experience of the population needing

hospital treatment for asthma or COPD at the age of 50-54 years 1256 (L)

Jones JM see Dowson LJ Jones PW see Barley EA Jijnsson E see Larsson L-G; R&mark E Jorfeldt L see Norman M Jiirres RA see Kirsten DK Joseph L see Demissie K Jounieaux V see Hellmuth D Joyce C see Brown I

Kaad P-H see Berg A von Kalayc 6 see Saraqlar Y

INDEX

Kalyoncu AF, Selquk ZT, Ciilit L. Epidemiological studies of adult bronchial asthma in Turkey 792 (L)

Kamei T see Hojo S; Yamanouchi H Kaminski N see Kreiss Y Kamma H see Ishikawa H Kampelmacher MJ, Kestern RG van, Aslbach GPJ,

Melissant CF, Wynne HJ, Douze JM: Lammers J-WJ. Characteristics and complaints of patients prescribed long-term oxygen therapy in the Nether!ands 70-75

Kapsner CO see Murata GH Karam G see Omidvari K Katz I see Fink G Kauppi P, Laitinen LA, Laitinen H, Kere J, Laitiinen T.

Verification of self-reported asthma and allergy in subjects and their family members volunteering for gene mapping studies 1281-8

Kauppinen R, Sintonen H, Tukainen H. One-year economic evaluation of intensive vs conventional patient education and supervision for self-management of new asthmatic patients 300-7

Kawiak J see Domagala-Kulawik J Kealy WF see Henry M Keaney NP see Parameswaran K Kearney SE, Graham DR, Atherton ST. Acute severe

asthma treated by mechanical ventilation: a comparison of the changing characteristics over a 17-year period 7 16-2 1

Keistinen T, Tuuponen T. Careful consideration needed with diagnoses of heart disease in COPD patients 1256-7 (L)

Tuuponen T, Kivela S-L. Survival experience of the population needing hospital treatment for asthma or COPD at age 50-54 years 568-72

Kere J see Kauppi P Kerr KM see Devereux G Kestern RG van see Kampelmacher MJ Khalil MM, Rifaie OA. Electrocardiographic changes in

obstructive sleep apnoea syndrome 25527 Ki SY see Uh S-T Kido M see Nikaido Y Kiely JL, Donohoe P, Bresnihan B, McNicholas WT.

Pulmonary fibrosis in polymyositis with the Jo-l syndrome: an unusual mode of presentation 1167-9 (CR)

Kim HT see Uh S-T Kim YH see Uh S-T Kirstein D see Schtirmann M Kirsten DK, Taube C: Lehnick B, Jorres RA, Magnussen

H. Exercise training improves recovery in patients with COPD after an acute exacerbation 1191-8

Kishore Kumar S see Doherty MJ Kivell S-L see Keistinen T Kivity S see Nutman A Klainman E see Fink G Klein JJ see Palen J van der Klinkhamer PJ see Roelofs PM Knuistingh Neven A see Chisholm SL Knutsen SF see McDonnell WF Kobayashi M see Ohta T Koeter GH see Breukink SO Kok-Jensen A see Seersholm N Kon OM, Goyai M, Filley E, Gleissberg G, Cunningham

D, Rook GAW, Shaw RJ. Mycobucterium vaccae: a study of safety and outcome measures 597-S (SR)

Konson N see Weiner P Koorn M see Breukink SO

Kopferschmitt-Kluber MC, Frossard N, Rohde G, Pauli G. Increase in non-specific bronchial hyperresponsiveness without specific response to isocyanate in isocyanate- induced asthma: a pilot study 1093-8

Kopp C see Vervloet D Korn SH, Thunnissen FBJM, Wesseling GJ, Arends J-W,

Wouters EFM. Glucocorticoid receptor mRNA levels in bronchial epithelial cells of patients with COPD: influence of glucocorticoids 1102-9

Koyama H, Nishimura K, Ikeda A, Tsukino M, Izumi T. A comparison of different methods of spirometric measurement selection 4988504;

Comparison of four types of portable peak flow meters (Mini-Wright, Assessm Pulmo-graph and Wright Pocket meters) 505-l 1

Krag Jacobsen G see Clementsen P Kramer M see Fink G Kreiss Y, Schwartz E, Kaminski N, Raanani P, Schiby 6,

Zvas Z, Sidi Y. Unique pulmonary presentation of intravascular large cell lymphoma 1087-9

Kreukniet J see Jansons H Kreuzer H see Andreas S Kristensen MS; Milman N; Jarnvig I-L. Pulse oximetry at

fibre-optic bronchoscopy in local anaesthesia: indica- tions for postbronchoscopy oxygen supplementation? 432-7

Kumada H see Yasuda N Kumaradevan J see Hamid S Kunkel G see Matthys D

la Rosa M see Berg A von Labinjoh C, Selby C. Dermatomyositis associated with

small cell carcinoma of the lung: dramatic response to corticosteroid therapy 601-6 (CR)

Lai Y-F see Liu S-F Laitiinen T see Kauppi P Laitinen H see Kauppi P Laitinen LA see Kauppi P; Lijfdahl C-G Lam W-K see Tsang KWT Lammers J-WJ see Kampelmacher MJ Lan R-S see Huang C-C Landers A see Yung B Landers R see Henry M Lane SJ. Leukotriene antagonism in asthma and rhinitis

7955809 Lange P see Vestbo J Langevitz P see Aharon A Langton Hewer S, Hobbs J: Reid F, Lenney W. Pred-

nisolone in acute childhood asthma: clinical responses to three dosages 541-6

Larsen F see Norman M Larsson K see Wang Z; Zetterlund A Larsson L-G, Lundback B, Jiinsson E, Lindberg A,

Sandstrom T. Are symptoms of obstructive sleep apnoea syndrome related to bronchitic symptoms or lung function impairment? Report from the Obstruc- tive Lung Disease in Northern Sweden Study 283-8

Larsson PH see Zetterlund A Laserna B see Perez de Llano LA Laub M see Milman N Lay-Yee R see Gilthorpe MS Leach CL. Improved delivery of inhaled steroids to the

large and small airways (S.A.) 3-8 Lebowitz MD see McDonnell WF Lebzelter J see Fink G

Lee BW see Chew FT Lee M see Skwarski K Lee P see Chee CBE Lee T-Y see Liu S-F Legge JS see Devereux G Lehnick B see Kirsten DK Leitch AG see Simpson AJ Lenney W see Langton Hewer S Lensmar C, Elmberger G, Skiild M, Eklund A. Smoking

alters the phenotype of macrophages in induced sputum 415-20

Leung JCK see Hoheisel G Lewis SA, Britton JR. Consistent effects of high socioeco-

nomic status and low birth order, and the modifying effect of maternal smoking on the risk of allergic disease during childhood 123744

Liipo K see Seppala O-P Liistro G, Rombaux P, Dury M, Pieters T, Aubert G,

Rodenstein DO. Effects of Breathe Right@ on snoring: a polysomnographic study 106669

Lim G-I see Uh S-T Lim S, MacRae KD, Seed WA, Roberts CM. The value of

FEV, in screening subjects with stable COPD for PaO, ~7.3 kPa in patients qualifying for long-term 0, therapy 1122-6

Lin A-S. see Liu S-F Lin M-C see Huang C-C Lin W-C see Perng R-P Lindberg A see Larsson L-G Lindholm L-H see Montnemery P Lindholm N see Norrman E Liu JM see Perng R-P Liu S-F, Lee T-Y, Wong S-L, Lai Y-F, Lin A-S. Transient

cortical blindness: a complication of bronchial artery embolization 98336

Lium DJ see Murata GH Llopis R see Cremades MJ Liifdahl C-G, Postma DS, Laitinen LA, Ohlsson SV,

Pauwels RA, Pride NB. The European Respiratory Society study on chronic obstrutive pulmonary disease (EUROSCOP): recruitment methods and strategies 467-72

see also Bondesson E; Montnemery P; Nana A Losa Garcia JE, Mateos Rodriguez F, Jimenez Lopez A,

Garcia Salgado MJ, Martin de Cabo MR, Perez Losada J, Perez Arellano JL. Effect of cycolosporin A on inflammatory cytokine production by human alveolar macrophages 722-8

Lbtvall J see Palmqvist M Lijwhagen 0 see Palmqvist M Luburich P see Xaubet A LudeHa MD see Rodriguez MC Liideritz B see Schafer H Lundback B see Larsson L-G; Montnemery P; Norrman E;

Ronmark E : 7

Macchioni P see Di Franc0 A Mackay TW, Hulks G, Douglas NJ. Non-adrenergic, non-

cholinergic function in the human airway 461-6 MacKenzie DIC see Frost GD MacNee W see Skwarski K MacRae KD see Lim S Maesen FPV see Noord JA van Magnussen H see Kirsten DK Majori M see Pesci A

Mak V see Janes SM Makayama T see Matsumoto K Malmberg P see Wang Z Mamun M see Alcock SM; Connolly CK Manninen A see Wang Z Manousos 0 see Tzanakis N Manresa F see Escarrabill J Manuel Valle J see Valdes L Maran R see Aharon A Maranetra N see Nana A Marchesini L see Baraldi E Marin A see Comet R Marin J see Prieto L Marques-Magallanes JA, Storer TW, Cooper CB. Tread-

mill exercise duration and dysponea recovery time in chronic obstructive pulmonary disease: effects of oxygen breathing and repeated testing 735-8

Marshall BG, Wilkinson RJ, Davidson RN. Pathogenesis of tropical pulmonary eosinophilia: parasitic alveolitis and parallels with asthma 1-3

Martin de Cabo MR see Losa Garcia JE Martinez MT see Miravitlles M Martinez Odriozola P, Ferrer0 0, Jauregui I, Miguel F.

Alglucerase treatment of type 1 Gaucher disease with pulmonary involvement 1370-2

Martini T see Nutini S Maruyama M see Ohta T Mata I see Perez de Llano LA Mateos Rodriguez F see Losa Garcia JE Matera MG see Cazzola M Mathalone B see Yung B Matsuda R see Tomita H Matsuda T see Fujimura M Matsumoto K, Hashimoto S, Gon Y, Makayama T,

Takizawa H, Horie T. N-Acetylcysteine inhibits IL-la- induced IL-8 secretion by bronchial epithelial cells 512-15

Matsumoto Y see Suzuki Y Matthys H, Nowak D, Hader S, Kunkel G. Efficacy of

chlorofluorocarbon-free beclomethasone dipropionate 400 ,uglday delivered as an extrafine aerosol in adults with moderate asthma (S.A.) 17-22

Maury E, Doyon F, Guidet B, Moty A, Offenstadt G. Drainage of spontaneous pneumothorax using an intravenous catheter. Immediate and long-term results 961-2 (TN)

Mavrofridis E see Patakas D McConnell SA see Waller DA McDonnell WF, Enright PL, Abbey DE, Knutsen SF,

Peters JA, Burchette RJ, Lebowitz MD. Spirometric reference equations for older adults 91421

McGavin C, Hughes P. Finger clubbing in malignant mesothelioma and benign asbestos pleural disease 691-2 (SR)

McGibbon K see Peckham DG McGivern DV see Doherty MJ McKenzie SA see Picciotto A McLean AN, Semple Pd’A, Franklin DH, Petrie G, Millar

EA, Douglas JG. The Scottish multi-centre prospective study of bronchoscopy for bronchial carcinoma and suggested audit standards 1110-l 5

McLeod DT see Hill AT McNicholas WT see Kiely JL McRae WM, Wong CS, Jeffery GM. Endobronchial non-

Hodgkin’s lymphoma 975-7 (CR)

Mota S SEE Gomez J Motomiya M see Shiraishi K Moty A see Maury E Mouzas J see Tzanakis N Mower WR; Sachs C, Nicklin EL, Safa P, Baraff LJ. Pulse

oximetry in smokers 989-90 (L) Miihlen F von zur see Andreas S Miiller-Quernheim J. Sarcoidosis: clinical manifestations,

staging and therapy (part II) 140-9 see also Schiirmann M; Zissel G

Miiller-Suur C see Zetterlund A Munch E see Bisgaard H Munch EP see Milman N Muiioz X see Orriols R Murata GH, Kapsner CO, Lium DJ, Busby HK. Time

course of respiratory decompensation in chronic obstructive pulmonary disease: a prospective double- blind study of peak flow changes prior to emergency department visits 93641

Mushtaq M see Dowson LJ Myers MJ see Ussov WY Mygind N; Dahl R, Nielsen LP. Effect of nasal inflamma-

tion and of intranasal anti-inflammatory treatment on bronchial asthma 547-9

Meissner H-H, Robinson L, Dubinett SM, Santiago SM. Pulmonary edema as a result of chronic upper airway obstruction 11746 (CR)

Melillo G see DahlCn B Melissant CF see Kampelmacher MJ Memendez R see Cremades MJ Mendel S see Nutman A Metlay JP, Atlas SJ, Borowsky LH, Singer DE. Time

course of symptom resolution in patients with community-acquired pneumonia 113742

Michaelopoulos A, Anthi A, Rellos K, Geroulanos S. Effects of positive end-expiratory pressure (PEEP) in cardiac surgery patients 858-62

Nikolaides A, Antzaka C, Deliyanni M, Smirli A, Geroulanos S, Papadimitriou L. Change in anaesthesia practice and postoperative sedation shortens ICU and hospital length of stay following coronary artery bypass surgery 1066-70

Michel F-B see Demoly P Micheletto C see Cogo AL Migliori GB see Spanevello A Miguel F see Martinez Odriozola P Milic-Emili J see Hayot M Millar EA see McLean AN Millar-Jones L, Ryley HC, Pauli A, Goodchild MC. Trans-

mission and prevalence of Buskholderia cepacia in Welsh cystic fibrosis patients 178-83

Milman N, Laub M, Munch EP, Angelo HR. Serum concentrations of lignocaine and its metabolite monoethylglycinexylidide during fibreoptic bronchoscopy in local anaesthesia 4043

Msller Pedersen F. Idiopathic pulmonary haemosiderosis. Epidemiology, pathogenic aspects and diagnosis 902-7

see also Kristensen MS Minatoguchi S see Yasuda N Miravitlles M, Vidal R: Barros-Tizhn JC, Bustamante A,

Espafia PP, Casas F, Martinez MT, Escudero C: Jardi R. Usefulness of a national registry of alpha-l- antitrypsin deficiency. The Spanish experience 118 l-7

Miyake S see Shishido H Miyawaki H see Fujita J Molema J see Schayk CP van Merller Pedersen F see Milman N Monasterio C see Escarrabill J Manse E, Fiz JM, Izquierdo J, Alonso J, Co11 R, Rose11 A,

Morera J. Quality of life in severe chronic obstructive pulmonary disease: correlation with lung and muscle function 221-7

Montnemery P, Adelroth E, Heuman K, Johannisson A, Johansson S-A; Lindholm L-H, Lundback B, Lijfdahl C-G. Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden 133745

Moon SH see Uh S-T Moorat A see Berg A von Morales C see Prieto L Moreda M see Perez de Llano LA Morera J see Fiz JAF; Monso E Morgan MDL see Revill SM; Singh SJ Mori T see Tomita H Morishima Y, Satoh H, Ohtsuka M, Yazawa T: Yamashita

Y, Hasegawa S. Primary mediastinal nonseminomatous germ cell tumour in an adult female 882-4 (CR)

Mark M see Carlsen K-H Morrison D see Skwarski K

Nagata N see Nikaido Y Nageh TT, du Bois RM. Non-invasive ventilation in hyper-

capnic respiratory failure secondary to sclerodermic chest wall restriction 1170-2 (CR)

Naik SK see Carter R Naish J see Picciotto A i Naito T see Ishikawa H Nakamura Y see Hoshino GH Nana A, Youngchalyyud P, Maranetra N: Boe J, Lofdahl

C-G, Selroos 0, St&l E. ,&agonists administered by a dry powder inhaler can be used in acute asthma 167-72

Narvestadt E see Jensen EJ Negayama K see Fujita J Nelson S see Omidvari K Neri M see Spanevello A Nicholson AA see Doherty MJ Nicklin EL see Mower WR Nielsen LP see Mygind N Nieminen MM see Hedman J; Seppala O-P Niime T see Tomita H Nikaido Y, Nagata N, Yamamoto 7, Yoshii C, Ohmohi H,

Kido M. A case of allergic bronchopulmonary aspergillosis successfully treated with itraconazole 118-19 (CR)

Nikander K see Bisgaard H Nikolaides A see Michalopoulos A Nishigaki K see Yasuda N Nishimura K see Koyama H Noliet AS, Vansteenkiste JF, Demedts MG. Broncholithi-

asis: rare but still present 96335 (CR) Nomura-M see Fujimura M; Yasuda N Noord JA van, Smeets JJ, Maesen FPV. A comparison of

the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction 1346-5 1

Norman M, Hillerdal G, Orre L, Jorfeldt L, Larsen F, Cederlund K, Zetterberg G; Unge G. Improved lung function and quality of life following increased elastic recoil after lung volume reduction surgery in emphysema 653-8

Norrman E, Plaschke P, Bjornsson- E, Rosenhall L, Lundback B, Jansson C, Lindholm N, Boman G. Prevalence of bronchial hyper-responsiveness in the southern, central and northern parts of Sweden 480-7

Nowak D see Gillissen A; Matthys D Nukiwa T see Shiraishi K Numata M see Suzuki Y Nutini S, Martini T, Righi R. Long-term treatment of

asthmatic patients with salmeterol vs slow-release theophylline 683-90

Nutman A, Solomon Y, Mendel S, Nutman J, Hines E, Topilsky M, Kivity S. The use of a neural network for studying the relationship betwen air pollution and asthma-related emergency room visits 11999202

Nutman J see Nutman A Nybo Jensen B see Wilcke JTR Nyholm J-E see SeppLll O-P

O’Connor BJ see Davies RJ O’Neill A see Roberts CM O’Reilly JF, Weir DC, Banham S, Basran GS, Boyd G,

Pate1 KR. Is high-dose flutacasone propionate via a metered-dose inhaler and Volumatic as efficacious as nebulized budesonide in adult asthmatics? 11 l-17

Obayashi Y see Fujita J Offenstadt G see Maury E Ogisu N see Tomita H Ohara M see Fujita J Ohchi T, Tanaka H, Shibuya Y, Shibusa T, Inuzuka M,

Satoh M, Abe S. Thymic carcinoid with mutinous stroma: a case report 880-2 C(R)

Ohlsson SV see Lijfdahl C-G Ohmohi H see Nikaido Y Ohno A see Yasuda N Ohta T, Yamashita N, Maruyama M, Sugiyama E,

Kobayashi M. Cigarette smoking decreases interleukin-8 secretion by human alveolar macrophages 922-7 !, 1

Ohtsuka M see Ishikawa H; Morishima Y Ohtsuki Y see Yamanouchi H Ohtusuki Y see Hojo S Okubo T see Suzuki Y Omenaas E see Svanes C Omidvari K, de Boisblanc BP, Karam G, Nelson S,

Haponik E, Summer W. Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis 1032-9

Ong KC, Clerk AA. Comparison of the sever& of sleep- disordered breathing in Asian and Caucasian patients seen at a sleep disorders center 843-8

Ooi BC see Chew FT i , Ormerod LP, Horsfield N, Alani FSS. How frequently do

endobronchial secondaries occur in an unselected series? 599-600 (SR)

Orre L see Norman M Orriols R, Muiioz X, Alvarez A, Sampol G. Chest CT

scanning: utility in lung endometriosis 876-7 (CR) Osman L. Health habits and illness behaviour: social

factors in patient self-management 150-5 Overdiep SH see Pomp J

Paggiaro PL see Di Franc0 A Palen J van der, Klein JJ, Zielhuis GA, Herwaarden CLA

van. The role of self-treatment guidelines in self- management education for adult asthmatics 668-75

Palmberg L see Zetterlund A Palmqvist M, Pettersson K, Sjiistrand M, Andersson B,

Lawhagen 0, Liitvall J. Mild experimental exacerbation of asthma induced by individualised low-dose repeated allergen exposure. A double-blind evaluation 1223-30

Panagou P see Tzanakis N Pang SC. Chest radiography and tuberculosis case-finding

in Western Australia 1988202 Pannekoek BJM see Pomp J Pantin C see Peckham DG Papadimitriou L see Michalopoulos A Parameswaran K, Hildreth AJ, Chadha D, Keaney NP,

Taylor IK, Bansai SK. Asthma in the elderly: under- perceived, underdiagnosed and undertreated; a community survey 573-7

Park CS see Uh S-T Partridge MR, Harrison BDW, Bellamy D, Silverman M.

The British Asthma Guidelines - their production, dissemination and implementation 1046652

Parwer S see Abel AT Pastor A see Cremades MJ Patakas D, Andreadis D, Mavrofridis E, Argyropoulou P.

Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive disease 1116-21

Pate1 KR see O’Reilly JF Patsourakis G see Bouros D Pauli A see Millar-Jones L Pauli G see Kopferschmitt-Kluber MC Pauweis R see Ringdal M, Pauwels RA see Lijfdahl C-G Pavia D see Hasani A Pavord I see Dawson S Peake MD see Biernacki W Peckham DG, McGibbon K, Tonkinson J, Plimbley G,

Pantin C. Improvement in patient compliance with long-term oxygen therapy following formal assessment with training 1203-6

Pedersen B see Jensen EJ Pela R see Vervloet D Penela P see Valdes L Penrose A see Frost GD Perez Arellano JL see Losa Garcia JE Perez de Llano LA, Soilan JL, Garcia Pais MJ, Mata I,

Moreda M, Laserna B. Idiopathic bronchiolitis obliterans with organizing pneumonia presenting with adult respiratory distress syndrome 884-6 (CR)

Perez Losada J see Losa Garcia JE Perks WH see Dowson LJ Perng R-P. Chen Y-M, Wu M-F, Chou K-C, Lin W-C, Liu

JM, Whang-Peng J. Phase II trial of intrapleural paclitaxel injection for non-small lung cancer patients with malignant pleural effusions 473-9

Perrigault PF see Hayot M Perruchoud AP see Hoheisel G Pesci A, Majori M, Cuomo A, Borciani N, Bertacco S,

Cacciani G, Gabrielli M. Neutrophils infiltrating bronchial epithelium in chronic obstructive pulmonary disease 863-70

Peters AM see Ussov WY Peters JA see McDonnell WF Petri H see Chisholm SL Petrie G see McLean AN

INDEX

Pettersson K see Palmqvist M Pham B see Aaron SD Picca V see Resta 0 Picciotto A, Hubbard M, Sturdy P, Naish J, McKenzie SA.

Prescribing for persistent cough in children 63841 Pierce JD; Clancy RL, Trank JW; Burris J. Diaphragm

shortening and intrathoracic pressure during hypercapnia in rats 4-8

Pieters T see Liistro G Pietinalho A see Seppala O-P Pifiiro-Amigo L see Blanco-Perez J Pison C see Devouassoux G Pistelli R see Antonelli Incaizi R Plaschke P see Norrman E Platts-Mills T see Ronmark E Plimbley G see Peckham DG Poh SC see Chee CBE Pokorna H see Striiz I Pomp J, Pannekoek BJM, Overdiep SH. Pleomorphic

adenoma and severe tracheal obstruction 889-91 (CR) Parcel JM see Gazquez I Porta R see Clini E Postma DS see Lofdahl C-G Postmus PE see Smit HJM Potter JF see Dawson S Poussa T see Hedman J Prefaut Ch see Hayot M Prentice AG see Fitch PS Prescott E see Vestbo J Prescott RJ see Alcock SM; Connolly CK Price DB, Appleby JL. Fluticasone propionate: an audit of

outcomes and cost-effectiveness in primary care 351-3 Cargill K, Wolfe S, Darby H. Salmeterol xinafoate: an

analysis of outcomes and cost-effectiveness using a primary care database 1302-4 (SR)

Pride NB see Liifdahl C-G Prieto L, Gutierrez V, Morales C, Marin J. Differences

in sensitivity, maximal response and position of the concentration-response curve to methacholine between asthmatics, patients with allergic rhinits and healthy subjects 88-94

Psathakis K see Bouros D

Quebe-Fehling E see Thomson NC; Vervloet D Quirk FH see Barley EA

Raanani P see Kreiss Y Rajesh PB see Waller DA Ramirez J see Soler N Ramonatxo M see Hayot M Rees PJ see Corden Z Reichenberger F see Hoheisel G Reid DW, Bromly CL, Stenton SC, Hendrick DJ, Bourke

SJ. A double-blind placebo-controlled study of the effect of influenza vaccination on airway responsiveness in asthma 1010-11

Reid F see Langton Hewer S Reintoft I see Benstrup KE Rellos K see Michaelopoulos A Remond A see Hellmuth D Resta 0, Guido P, Picca V, Sabato R, Rizzi Ma Scarpelli F,

Sergi M. Prescription of nCPAP and nBIPAP in obstructive sleep apnoea syndrome: Italian experience in 105 subjects. A prospective two-centre study 820-7

Revill SM, Morgan MDL. The cardiorespiratory response to submaximal exercise in subjects with asthma following pretreatment with controlled release oral salbutamol and high-dose inhaled salmeterol 105338

Rezaian GR see Emad A Ribera G see Comet R Riera M see Fiz JAF Rifaie OA see Khalil MM Righi R see Nutini S Ringdal M, Derom E, Wahlin-Boll E, Pauweis R. Onset

and duration of action of single doses of formoterol inhaled via Turbuhalera 10 17-2 1

Ringdal N see Ekstriim T Rivas MC see Gazquez I Rizzi M see Resta 0; Sergi M Roberts CM, Franklin J, O’Neill A, Roberts RP, Ide J,

Hanley ML, Edwards J. Screening patients in general practice with COPD for long-term domiciliary oxygen requirement using pulse oximetry 1265-8

see also Lim S Roberts RP see Roberts CM Robinson BWS see Venaille TJ Robinson L I see Meissner H-H Rota J, Burgos F: Barbera JA, Sunyer J: Rodriguez-Roisin

R, Castellsague J, Sanchis J, Antbo JM, Casan P, Clausen JL. Prediction equations for plethysmographic lung volumes 454-60

see also Castellsague J; Xaubet A Rota-Serrano R see Blanco-Perez J Rochat T see Janssens J-P Rodenstein DO see Liistro G Rodriguez MC, Capurro M, Gomez F, Ludeca MD.

Migratory pulmonary infiltrates 108 14 Rodriguez-Roisin R see Rota J; Soler N; Xaubet A Roelofs PM, Klinkhamer PJ, Gooszen HC. Hypersensitiv-

ity pneumonitis probably caused by cyclosporine. A case report 1368-70 (CR)

Rohde G see Kopferschmitt-Kluber MC Rokkas T see Bouros D Rombaux P see Liistro G Ronmark E: Lundback B, Jiinsson E, Platts-Mills T.

Asthma, type-l allergy and related conditions in 7- and g-year-old children in Northern Sweden: prevalence rates and risk factor pattern 316-24

Rook GAW see Kon OM Roomi J see Yohannes AM Rose11 A see Monso E Rosenhall L see Norrman E Roth M see Hoheisel G Rotondetto S see Hasani A Roy TM see Byrd RP Rozman C see Soler N Rubens M see Carr DH Rubio M see Gazquez I Runnerstrom E see Ekstrom T Ruocco L see Di Franc0 A Ryan DP see Hamid S Ryan G see Venaille TJ Ryley HC see Millar-Jones L

Sabato R see Resta 0 Sachs C see Mower WR Safa P see Mower WR Sahla H see Demoly P Samiou M see Tzanakis N

INDEX

Sampol G see Orriols R Sanakaran R see Dev D Sanchis J see Gomez J; Rota J Sandstrom T see Larsson L-G Sano H see Yasuda N Sans J see Comet R Santiago SM see Meissner H-H Sanyai SC see Abel AT Saraclar Y. Epidemiological studies of adult bronchial

asthma in Turkey.,792-3 (L) Sekerel BE, Kalayc 0, Cetinkaya F, Adalioglu G, Tuncer

A, Tezcan S. Prevalence of asthma symptoms in school children in Ankara, Turkey 203-7

Sasaki H see Shiraishi K Sato S see Tomita H Satoh H see Ishikawa H; Morishima Y Satoh M see Tanaka H Satta A see Spanevello A Sawa T see Yasuda N Scarduelli C see Clini E Scarpelli F see Resta 0 Schaaning J, Strom K, Boe J. Do patients using long-term

liquid oxygen differ from those on traditional treatment with oxygen concentrators and/or compressed gas cylinders? A comparison of two national registers 84-87

Schafer H, Ewig S, Hasper E, Ltideritz B. Failure of CPAP therapy in obstructive sleep apnoea syndrome: predictive factors and treatment with bilevel-positive airway pressure 208-l 5

Schans CP van der see Breukink SO Schauer J see Hoheisel G Schayk CP van, Dekhuijzen PNR, Gorgels WJMJ,

Grunsven PM van, Molema J, Herwaarden CLA van, Wee1 C van. Are anti-oxidant and anti-inflammatory treatments effective in different subgroups of COPD? A hypothesis 1259-64

Schiby G see Kreiss Y Schlaak M see Schiirmann M Schnohr P see Vestbo J Schriider E see Carlsen K-H Schiirmann M, Bein G, Kirstein D, Schlaak M, Mtiller-

Quernheim J, Schwinger E. HLA-DQBl and HLA- DPBl genotypes in familial sarcoidosis 649-52

Schwartz E see Kreiss Y Schwinger E see Schiirmann M Seale JP, Harrison LI. Effect of changing the fine particle

mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics (S.A.) 9-16

Seed WA see Lim S Seersholm N, Kok-Jensen A. Intermediate aiantitrypsin

deficiency PiSZ: a risk factor for pulmonary emphysema? 24 l-5

Sekerel BE see Saraclar Y Selby C see Labinjoh C Selcuk ZT see Kalyoncu AF Selroos 0 see Nana A Semple Pd’A see McLean AN Seppala O-P, Herrala J, Hedman J, Alanko K, Liipo K,

Terho E, Pietinalho A, Nyholm J-E, Nieminen”MM. The bronchoprotective efficacy of salbutamol inhaled from a new metered-dose powder inhaler compared with a conventional pressurized metered-dose inhaler connected to a spacer 578-83

Sergi M, Rizzi M, Greco M, Andreoli A, Bamberga M, Castronovo C, Ferini-Strambi L. Validity of diurnal sleep recording performed by an ambulatory device in the diagnosis of obstructive sleep apnoea 216-20

see also Resta 0 Sevestre H see Hellmuth D Sharara A see Spanevello A Shaw RJ see Kon OM Sheung SW see Wong CF Shibusa T see Tanaka H Shibuya Y see Tanaka H Shimizu S see Tomita H Shinagawa S see Fujimura M Shiraishi K, Sasaki H, Yaekashiwa M, Motomiya M,

Nukiwa T. Total respiratory system compliance after thoracoplasty 810-14

Shishido H, Deguchi K, Miyake S, Akagawa S, Yoshizawa Y. Mulitple drug-resistant Nocardia asteroides isolated from a patient with pulmonary nocardiosis 873-5 C(R)

Shlomo M see Fink G Shneerson J see Jackson M Short PE see Boldy DAR Shtrasburg S, Livneh A see Aharon A Shurvinton J see Dowson LJ Siafakis N see Tzanakis N Sidi Y see Kreiss Y Silverman M see Partridge MR Silvert BD see Vervloet D Sim JJ see Hoshino GH Simpson AJ, Tweeddale PM, Crompton GK. Starting

home nebulizer therapy: patients’ expectations and subsequent outcome at 2 months 1000-2

Watt B, Heald SH, Sudlow MF, Leitch AC. The management of pulmonary tuberculosis in adults notified in Scotland 1289-94

Simpson JCG, Callaway MP, Taylor PM, Hardy CC. Recurrent venous obstruction caused by sarcoidosis 785-6 (CR)

Singer DE see Metlay JP Singh SJ, Smith DL, Hyland ME, Morgan MDL. A short

outpatient pulmonary rehabilitation programme: immediate and longer term effects on exercise performance and quality of life 1146-54

Sintonen H see Kauppinen R Sjijstrand M see Palmqvist M Skiild M see Lensmar C Skwarski K, Morrison D, Barratt A, Lee M, MacNee W.

Effects of hypoxia on renal hormonal balance in normal subjects and in patients with COPD 13313-6

Slater AL see Hill LS Smeets JJ see Noord JA van Smirli A see Michalopoulos A Smit HJM, Chatrou M, Postmus PE. The impact of spon-

taneous pneumothorax, and its treatment, on the smoking behaviour of young adult smokers 1132-6

Smith DL see Singh SJ Smith MEF see Fitch PS Sobradillo V see Ekstrdm T Soilen JL see Perez de Llano LA ” Soler N, Babera IA, Ramirez J, Bat116 M, Rozman C,

Rodriguez-Roisin R. Pulmonary Langerhans’ cell histiocytosis following autologous haemopoietic progenitor cell transplantatibn 1253-5 (CR)

Soliman S see Bondesson E; Ekstrijm T Solomon Y see Nutman A ’

Spanevello A, Migliori GB, Satta A, Sharara A; Ballardini L, Ind PW, Neri M. Bronchoalveolar lavage causes decrease in PaO, increase in (A-a) gradient value and bronchoconstriction in asthmatics 191-7

Spiteri MA see Hasani A Spitzer S see Fink G Spyt T see Williams T Staal-van den Brekel AJ, Dentener MA, Drent M, Velde

GPM ten, Bum-man WA, Wouters EFM. The enhanced inflammatory response in non-small cell lung carcinoma is not reflected in the alveolar compartment 76-83

Stableforth DE see Hill AT St%1 E see Nana A Stampone P see Davies RJ Steele R see Brown I Stenton SC see Reid DW Sternberg A see Weiner P Stevens J see Andreas S Stevenson RD see Carter R Stewart PM see Hill AT Storer TW see Marques-Magallanes JA Strijbos JH see Breukink SO Striz I, Pokorna H, Zheng L, Guzman J, Costabel U.

Different expression of integrins by mononuclear phagocytes in peripheral blood and BALF 1326-30

Strom K. Oral corticosteroid treatment during long-term oxygen therapy in chronic obstructive pulmonary disease: a risk factor for hospitalization and mortality in women.

see also Schaaning J Sturani C see Clini E Sturdy P see Picciotto A Such JJ see Comet R Sudlow MF see Simpson AJ Sugiyama E see Ohta T Summer W see Omidvari K Sunyer J see Castellsague J; Rota J Sutherland AM see Johnson PH Suzuki J see Suzuki Y Suzuki S see Suzuki Y Suzuki Y, Suzuki S, Numata M, Matsumoto Y, Suzuki J;

Ikeda H, Okubo T. Acute respiratory failure due to miliary tuberculosis in a patient with idiopathic CD4’ T-lymphocytopaenia 977-9 (CR)

Svanes C, Omenaas E, Eide GE, Fluge 0, Gulsvik A. Hospitalization for lung disease in early childhood and asthma symptoms in young adulthood 1003-9

Takahara J see Fujita J; Hojo S; Yamanouchi H Takizawa H see Matsumoto K Tamura T see Ikeda Y Tanaka H see Tanaka H Tattersfield Ae see Harrison TW Taube C see Kirsten DK ‘L Taylor IK see Parameswaran K Taylor PM see Simpson JCG Taylor RFH, Gaya H, Empey DW. A new approach to the

treatment of Xantlzoinonas maltoplzila respiratory infection in a patient with cystic fibrosis 3634 (CR)

Terho E see Seppala O-P Tezcan S see Saraqlar Y Thomas S see Ansari S

Thompson PJ, Davies RJ; Young WF: Grossman AB, Donnell D. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol (S.A.) 33-9

Thomson NC, Angus R; Quebe-Fehling E, Brambilla R. Efficacy and tolerability of formoterol in elderly patients with reversible obstructive airways disease 562-7

Thunnissen FBJM see Korn SH Tomioko H see Hoshino GH Tomita H: Sato S, Matsuda R, Ogisu N, Mori T, Niime T,

Shimizu S. Genetic polymorphism of the ACE in asthmatic patients 1305-10

Tonkinson J see Peckham DG Tony F see Devouassoux G Topilsky M see Nutman A Torrice MP see Antonelli Incaizi R Trank JW see Pierce JD Tsai Y-H see Huang C-C Tsang KWT, Lam W-K, ip M. Response of dermatomy-

ositis co-existing with non-small cell lung cancer to chemotherapy 788-90 (CR)

Tsao TCY see Huang C-C Tsinstzas OK see Dimopoulou I Tsukino M see Koyama H Tukainen H see Kauppinen R Tuncer A see Saraqlar Y Turner D see Fink G Tuuponen T see Keistinen T Tweeddale PM see Simpson AJ Tweel I van der see Jansons H Tzanakis N, Bouros D, Samiou M; Panagou P, Mouzas J,

Manousos 0, Siafakis N. Lung function in patients with inflammatory bowel disease 5 16622

see also Bouros D Tzelepis GE see Dimopoulou I

Ueda N see Yamanouchi H Uh S-T, Ki SY, Lim G-I, Moon SH, Jeong SW, Kim HT,

Kim YH, Park CS. The T cell receptor subsets of lymphocytes in bronchoalveolar lavage in patients with active pulmonary tuberculosis 408-14

Unge G see Norman M Ussov WY, Peters AM, Myers MJ, Glass DM, IIughes

JMB. Bimodal granulocyte transit time through the human lung demonstrated by deconvolution analysis 1163-6 (SC)

Vagaggini B see Di Franc0 A ValdCs L, Gonzalez-Juanatey JR, Alvarez D, Antunez J;

Manuel Valle J, Penela P, Alvarez-Sala R. Diagnosis of pulmonary veno-occlusive disease: new criteria for biopsy 979-83 (CR)

Van de Heyning P see Boudewyns A Vansteenkiste JF see Nollet AS Velde GPM ten see Staal-van den Brekel AJ Venaille TJ, Ryan G, Robinson BWS. Epithelial cell

damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum 23340

Verberne AAPH, Fuller R. An overview of nine clinical trials of salmeterol in an asthmatic population 777-82

Vervloet D, Ekstriim T; Pela R, Duce Gracia F, Kopp C, Silvert BD, Quebe-Fehling E, Della Cioppa 6,

INDEX

Di Benedetto G. A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease 83642

Vestbo J, Prescott E, Lange P, Schnohr P, Jensen G. Vital prognosis after hospitalization for COPD: a study of a random population sample 772-6

Vicente de Vera MC see Gazquez I Vidal R see Miravitlles M Vinciguerra A see Cazzola M Vitacca M see Clini E Vives M see Gazquez I

Wahlin-Boll E see Ringdal M Walamies MA. Thoracic gas compression profile during

forced expiration in healthy and asthmatic school- children 173-7

Wallace E see Dev D Waller DA, McConnell SA, Rajesh PB. Delayed referral

reduces the success of video-assisted thoracoscopic surgery for spontaneous pneumothorax 246-9

Walters S see Gilthorpe MS Wang YT see Chee CBE Wang Z, Manninen A, Malmberg P, Larsson K. Inhalation

of swine-house dust increases the concentration of interleukin-1 beta (IL-l/$ and interleukin-1 receptor antagonist (IL-lra) in peripheral blood 1022-7

Watanabe M see Yasuda N Waters K see Yohannes AM -* Wathen CG see Dev D Watson BL, Cormier RA, Harbeck RJ. Effect of pH on the

stability of methacholine chloride in solution 588-92 Watt B see Simpson AJ Watts T see Dowson LJ Webb DR. Efficacy of inhaled beclomethasone dipropion-

ate and budesonide in the treatment of asthma (S.B.) 7-14

Wee1 C van see Schayk CP van Weiner P, Konson N, Sternberg A, Zamir D, Fireman Z. Is

gastro-oesophageal reflux a factor in exercise-induced asthma? 1071-5

Weir DC see O’Reilly JF Wesseling GJ see Korn SW Whang-Peng J see Perng R-P Wheatley DJ see Carter R Wilcke JTR, Askgaard DS, Nybo Jensen B, Dossing M.

Radiographic spectrum of adult pulmonary tuberculosis in a developed country 493-7

Wilkinson I see Johnson PH Wilkinson RJ see Marshall BG Williams T, Gostelow B, Woods D, Spyt T. Apical pleural

mass developing following talc pleurodesis 358-64 CW

Wilson C see Adams JP Wilson RC see Gilthorpe MS Wirnsberger RM, de Vries J, Breteler MHM, Heck GL van,

Wouters SC, Drent M. Evaluation of quality of life in sarcoidosis patients 750-6

Witmeyer P see Devouassoux G Wolfe S see Price DB Wong CF, Yew WW, Chan CY, Au LY, Sheung SW,

Cheng AFB. Rapid diagnosis of smear-negative pulmonary tuberculosis via fibreoptic bronchoscopy:

utility of polymerase chain reaction in bronchial aspirates as an adjunct to transbronchial biopsies 815-19

Wong CS see McRae WM Wong S-L see Liu S-F Woods D see Williams T Wouters EFM see Korn SH; Staal-van den Brekel AJ Wouters SC see Wirnsberger RM Wu CP see Ho CL Wu M-F see Perng R-P Wynne HJ see Kampelmacher MJ

Xaubet A, Aguste P, Luburich P, Barbera JA, Carrion, Ayuso MC, Rota J, Rodriguez-Roisin R. Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis 33844

Yaekashiwa M see Shiraishi K Yamadori I see Hojo S; Yamanouchi H Yamaji Y see Fujita J; Hojo S Yamamoto T see Nikaido Y Yamanouchi H, Fujita J, Yoshinouchi T, Hojo S, Kamei T,

Yamadori 1, Ohtsuki Y, Ueda N, Takahara J. Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis 27338

Yamashita H see Ikeda Y Yamashita N see Ohta T Yamashita Y see Morishima Y Yamashita YT see Ishikawa H Yang C-T see Huang C-C Yasuda N, Gotoh K, Minatoguchi S, Asano K, Nishigaki

K, Nomura M, Ohno A, Watanabe M, Sano H, Kumada H, Sawa T, Fujiwara H. An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD 993-9

Yasui M see Fujimura M Yazawa T see Morishima Y Yeo JKS see Chee CBE Yew WW see Wong CF Yohannes AM, Roomi J, Waters K, Connolly MJ. Quality

of life in elderly patients with COPD: measurement and predictive factors 1231-6

Yoshii C see Nikaido Y Yoshinouchi T see Hojo S; Yamanouchi H Yoshizawa Y see Shishido H Young WF see Thompson PJ Youngchalyyud P see Nana A Yung B, Landers A, Mathalone B, Gyi KM, Hodson ME.

Diabetic retinopathy in adult patients with cystic fibrosis-related diabetes 871-2

Zacchello F see Baraldi E Zamir D see Weiner P Zetterberg G see Norman M Zetterlund A, Larsson PH, Miiller-Suur C, Palmberg L,

Larsson K. Budeonside but not terbulatine decreases phagocytosis in alveolar macrophages 162-6

Zheng L see Striz I Zielhuis GA see Palen .J van der Zissel G, Miiller-Quernheim J. Sarcoidosis: historical per-

spective and immunopathogenesis (part I) 126-39 Zvas Z see Kreiss Y

topical review - core · safety and efficacy of a high cumulative dose of salbutamol inhaled via...

Documents